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Crack cocaine seminar
Published in December 2008, Development of 
Ireland’s drug strategy 2000–2007, the eighth 
in the Health Research Board’s Overview 
series,1 analyses how the National Drugs 
Strategy 2001–2008 (NDS) was designed and 
developed, and how strategic management 
processes and governance arrangements 
were used to support implementation during 
its fi rst seven years. The objective is to gain 
insights into how these infrastructural elements 
may infl uence the realisation of the intended 
strategy and to explore options for the effective 
management of these elements. 
The analysis is based on the work of strategy 
theorist Henry Mintzberg.2 Over the course 
of a 30-year project researching and thinking 
about the strategy process, Mintzberg 
reached the conclusion that intended 
strategy is almost never the same as realised 
strategy. He explored how organisational 
leadership, structure and resources, as well as 
developments in the external environment, 
conspire to alter the course of the best-laid 
plans. He identifi ed fi ve ‘strategic forms’: 
strategies as intended plans, before action, and 
as realised patterns, after action; as deliberate 
strategy, when the intentions are more or less 
realised in the actions; as unrealised strategy, 
when the intentions are not realised; and as 
emergent strategy, when the patterns realised 
in action were never intended (see fi gure on 
p. 3). In analysing the development of Ireland’s 
drugs strategy within this framework, the 
overview highlights some underlying tensions. 
First, in setting direction, it is apparent 
that there has been an ongoing disconnect 
between the strategic objective and goals, 
which express an aspiration to reduce the 
harm to individuals, families and society from 
illicit drugs, and the operational objectives and 
key performance indicators, some of which 
have directed effort towards the prohibition of 
the illicit drug market and a drug-free society. 
Arguably, this ‘duality of approaches’ has 
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The Inter-Sectoral Crack Cocaine 
Strategy Group (ISCCSG), 
established by the late Tony 
Gregory through the North Inner 
City Community Policing Forum, 
hosted a seminar in Croke Park on 
24 February 2009. The purpose 
of the seminar was to try to plan 
a co-ordinated response to crack 
cocaine use in Ireland. Much of 
this response will be based on 
the fi ndings of a recent Health 
Research Board (HRB) report, 
Crack cocaine in the Dublin region – 
an evidence base for a crack cocaine 
strategy. A detailed report of the 
seminar will appear in the next 
issue of Drugnet Ireland.
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Thierry Charlois, manager of the Democracy, Cities & 
Drugs  project, part of the European Forum on Urban 
Safety, speaking at the crack cocaine seminar in Croke 
Park (Photo:  JJ Berkeley)
1 Crack cocaine seminar
1 HRB Overview 8: Development 
of Ireland’s drug strategy 
2000–2007 
3 Illicit drugs, alcohol and 
tobacco – understanding the 
policy issues 
5 Tenth annual Service of 
Commemoration and Hope 
5 Family Matters seminar 
6 Agreed Programme for 
Government – progress report 
2008
7 Cannabis use in Ireland 
9 Cannabis again reclassifi ed in 
the UK 
10 HSE outlines plans for drug and 
alcohol services in 2009
11 British–Irish Council meeting on 
drug misuse 
12 Review of the evidence base in 
drug prevention 
13 Tony Gregory 1947–2009 – an 
appreciation 
13 Substance use among Ireland's 
children 
14 Alcohol Implementation Group 
report 2008 
15 Alcohol pricing and promotion 
16 Maggie Bowen – an 
appreciation 
17 Assessment of early 
interventions for at-risk youth 
18 The process of youth 
homelessness 
19 An assessment of treatment 
needs in the North Eastern 
RDTF 
20 Directory of courses 2009 
20 Study on drug use in 
Clondalkin 
21 Kerry Life Education evaluation 
report 
22 Trends in alcohol and drug 
admissions to psychiatric 
facilities
23 Four cases of botulism among 
drug users 
24 The State Laboratory annual 
report 2007 
24 EU Drugs Action Plan evaluated
25 EU sets priorities for drug policy 
2009–2012 
27 Irish Prison Service annual 
report 2007 
28 From Drugnet Europe
29 In brief
30 Recent publications
31 Upcoming events
contents
2
created a space in which politicians have been 
able to manoeuvre, responding to different 
needs and audiences at different times. A critical 
challenge for effective strategic management is 
to achieve a balance between the competing 
demands for ambiguity and for precision, to 
ensure that political expediency does not crowd 
out consideration of the evidence base or, 
equally, that a slavish adherence to analytical 
certainty does not preclude innovation and 
bold policy. Two activities which would help to 
ensure effective management of this ambiguity 
are the formulation of a more rigorous system 
of performance measurement, for example 
a drug harm index, and a drive for more 
integrated performance through measuring and 
evaluating outputs and outcomes, rather than 
inputs and processes.
Second, with regard to informing strategic 
choices, two broad information types have been 
drawn on – scientifi cally derived, or evidence-
based, information, and public opinion. These 
two streams of information refl ect the rational 
and the non-rational aspects of the decision-
making process. During the lifetime of the NDS 
considerable effort has gone into building up 
the evidence base, but little comprehensive, 
systematic, scientifi c investigation of the nature 
of public opinion and the role of the media, has 
been undertaken. Furthermore, while there have 
been signifi cant strides in building the evidence 
base, there have been gaps in the use of overt 
analytical, modelling or evaluative approaches 
to policy development.
Third, an exploration of the mechanisms for 
co-ordinating the implementation of the NDS, 
and the allocation of responsibilities to individual 
entities for implementation, has highlighted 
some complex governance issues. While the 
various actors may share common aspirations 
with regard to the implementation of the 
NDS, they have other organisational priorities 
as well, which can run counter to the NDS 
objective. The recent OECD review of the Irish 
public service,3 suggests ways of overcoming 
such tensions, for example through adopting 
networked organisational forms and integrated 
performance management systems. 
Fourth, during the lifetime of the NDS, changes 
in the external environment have been 
amenable to control through means such as 
project planning, the mid-term review of the 
NDS, and the creation of the Emerging Needs 
Fund. Other changes, however, usually in the 
wider public policy environment, have had a 
more oblique connection to the NDS. It is not 
clear whether or how the intention behind 
initiatives, such as shifts in social inclusion policy 
or the introduction of drug testing in various 
contexts, has been compared with, or assessed 
against, the intentions behind the NDS. Steps to 
develop a system of strategic control 
that incorporates both emerging and intended 
strategies are canvassed. 
Although formal strategic plans are useful in 
ensuring the future is taken into account and in 
co-ordinating activities, they can never entirely 
remove the types of tensions outlined above, 
and neither can they eliminate uncertainty. 
In order to realise a strategic plan, Henry 
Mintzberg believed it is crucial to recognise that 
strategy development is a continuous process, 
based on real-time learning. Accepting this 
premise, this Overview on the development 
of Ireland’s drug strategy identifi es two 
requirements for effective strategy formation:
It is through continuously working with  ■
and managing the instabilities and confl icts 
which are an inherent part of strategy, 
that strategy moves forward in an effective 
manner. The tendency to reduce uncertainty, 
to seek stability by focusing on that which is 
amenable to control, distracts from the real 
task of the strategist. 
Continuous and inclusive debate and  ■
deliberation on the direction and contents 
of strategy is at the heart of effective 
strategy formation. It is through open, 
informed and critical debate, involving 
all players and drawing on all possible 
sources of information and all perspectives, 
that the insights gained from strategic 
implementation, and practical and 
acceptable options for resolving critical 
strategic tensions, are found. 
(Brigid Pike)
1. Pike B (2008) Development of Ireland’s drug 
strategy 2000–2007. HRB Overview Series 8. 
Dublin: Health Research Board.
2. Henry Mintzberg (1994) The rise and fall of 
strategic planning, New York: Prentice Hall, 
and (2007) Tracking strategies: towards a 
general theory. New York: Oxford University 
Press.
3. Organisation for Economic Co-Operation 
and Development (2008) Ireland: towards 
an integrated public service. OECD Public 
Management Reviews. Retrieved on 1 April 
2008 at www.oecd.org 
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Development of Ireland’s drug strategy (continued)
A recently published report on the development of national 
policies on illegal drugs, alcohol and tobacco in 17 member 
countries of the Council of Europe, including Ireland, 
shows that the policies lie along a continuum between one 
umbrella substance-use policy (e.g. Switzerland, France 
and Norway) and separate policies for different substances 
(e.g. the Netherlands and the United Kingdom). Ireland lies 
near the midway point, with three separate policies but a 
tendency to combine elements of illicit drugs and alcohol 
policy and practice.1
Having presented a synthesis of the 17 national reports, 
which are all included in the published document, the 
co-ordinator of the project, Richard Muscat, draws two 
main conclusions.
Develop a global policy framework
The common denominator among all the national policies 
is an overarching concern with health: this is the prime 
factor guiding most policy choices. To help analysis and 
understanding of the policy options, Muscat suggests that, 
in future, it may be appropriate to frame substance use 
policy within the context of health, and that the Council 
of Europe should take a lead in developing such a global 
policy framework. 
Muscat proposes that the model used to analyse the 17 
national policies on illicit drugs, alcohol and tobacco 
should be developed further in order to support the 
operation of such a framework. The model is based on the 
assumption that policy formulation in the area of substance 
use is infl uenced by three ‘proximal’ factors – civil society, 
science and practice – and that these in turn may be 
modifi ed by six ‘distal’ factors – public opinion, political 
ideology, theory, experiment, evidence base and outcomes 
(see diagram overleaf). 
The Irish case study contained in the report2 illustrates how 
the model can enhance our understanding of the nature of 
the policy issues.
Civil society•  refl ects the standpoint of citizens of a 
country, which in turn refl ects public opinions and 
political ideologies. The Irish case study contains 
examples of the contradictory views that can be 
taken. For example, while public opinion and 
political ideology converge regarding the nature of 
the illicit drug problem, they differ regarding how 
to respond. Although there is public support for a 
combined illicit drugs and alcohol strategy, there 
is continuing political reluctance to combine illicit 
drugs and alcohol in the one substance-use policy. 
Illicit drugs, alcohol and tobacco – 
understanding the policy issues 
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Science • comprises two main disciplines that are 
beginning to yield evidence that needs to be taken 
into account in formulating policy – epidemiology, 
which studies the incidence and prevalence of 
drug use, and neuroscience, which explores why 
psychoactive substances seem so attractive. Like 
the majority of countries, Ireland mainly considers 
the evidence from epidemiological studies. Muscat 
does not regard this as surprising as the questions 
posed by politicians are principally about the size of 
the problem and whether it is growing. Since 2004, 
data on problem alcohol use and on alcohol-related 
deaths in Ireland have been included alongside data 
on illicit drugs in the two national epidemiological 
databases administered by the Health Research Board 
(the National Drug Treatment Reporting System and 
the National Drug-Related Deaths Index). This new 
departure has the potential to infl uence the future 
development of illicit drugs and alcohol policy. 
Practice•  refers to the day-to-day management of 
problems associated with substance use: health, 
psychological, social or matters within the justice 
system. Modern practice is based on ‘good 
practice’, i.e. practice based on evidence and on 
the achievement of specifi c outcomes. Practice and 
policy may not always coincide, as demonstrated by 
the ongoing debate, in Ireland as elsewhere, as to 
whether harm-reduction practices are contrary to the 
1988 UN Convention on Drug Abuse, and as to their 
appropriateness and acceptability. 
Tobacco•  control is another interesting example of 
the interface between practice and policy. The Irish 
case study cites the conclusions of the Tobacco-Free 
Policy Review Group that reported in 2000 and 
which has determined the shape of Ireland’s tobacco 
policy ever since. While acknowledging that tobacco 
products, when used in the manner intended by the 
manufacturers, cause addiction followed by illness 
and premature death, the review group argues 
that prohibition is not an option: ‘A complete ban 
would, in our opinion, lead to the emergence of a 
substantial black market in smuggled products with 
its associated criminality.’ 
The policy model focuses on information inputs to the policy 
process. It does not factor in constraints, which may also 
infl uence policy. The Irish case study outlines how factors 
such as cultural attitudes, political processes, and structural 
and resourcing arrangements can restrict the options 
available to policy makers. 
Improve the use of research evidence in policy making
Muscat found that science plays a minor role in the 
decision-making process. In order to support the better 
use of research evidence in policy and practice, and thus 
facilitate the development of evidence-based policy, he 
identifi es three issues that need to be addressed: the co-
ordination of research efforts, access to information and the 
communication of fi ndings in a format that is digestible by 
policy-makers and the public at large. He outlines steps that 
the Research Platform of the Pompidou Group is taking in 
this regard: it has launched a second version of the 
Research Register, which aims to provide information on 
who is doing what in drug research, and in 2008 held 
a fi rst summer workshop for young drug researchers on 
communicating results.3 
(Brigid Pike)
1. Muscat R and Members of the Pompidou Group 
Research Platform (2008) From a policy on illegal drugs to 
a policy on psychoactive substances. Strasbourg: Council 
of Europe Publishing.
2. Pike B (2008) Irish drug policy and its link with alcohol 
and tobacco policies. In R Muscat et al., see Note 1 
above, pp. 91–107.
3. Information on the work of the Pompidou Group 
Research Platform, and the Research Register, may be 
found at www.coe.int/t/dg3/pompidou/Activities/
research_en.asp
Drugs, alcohol and tobacco - policy issues (continued)
Model of the proximal and distal factors infl uencing substance use policies (after Muscat 2008) 
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5Tenth annual Service of Commemoration 
and Hope 
On Sunday 1 February, the Family Support Network held 
its tenth annual Service of Commemoration and Hope, 
entitled ‘A decade of Hidden Grief, a Future of Hope?’, in 
remembrance of loved ones lost to drugs and related causes 
and to publicly support families living with the devastation 
that drug use causes.
The service in Our Lady of Lourdes Church, Sean McDermott 
Street, was preceded by a procession from the spire on 
O’Connell Street led by the Garda brass band. The service 
was attended by Mr John Curran TD, Minister of State with 
responsibility for drugs strategy, a representative of the 
Taoiseach, Garda Commissioner Fachtna Murphy, the Lord 
Mayor of Dublin, Eibhlin Byrne, Archbishop Diarmuid Martin 
and other religious representatives, as well family members, 
friends and representatives from family support groups 
throughout the island of Ireland and many people working 
in this area. 
Sadie Grace of the Family Support Network highlighted 
the importance of this annual service in allowing families to 
grieve openly while also celebrating the lives of the children 
they lost to drug use. She spoke of the achievements of the 
Family Support Network, including the involvement of the 
Network in establishing the National Drug-Related Deaths 
Index. She also voiced her fear of an increase in drug use in 
the current climate of recession.
Ruaidhri McAuliffe addressed the audience on behalf of 
the drug-users’ forum, Uisce (Union for Improved Services 
Communication and Education). He acknowledged the role 
that families play in both the treatment of and recovery from 
drug addiction. 
Minister Curran, Archbishop Martin and Fr Edmond Grace 
also addressed the gathering. Prayers and poems were 
read, accompanied by music provided by the Dublin West 
Community Church Music Group and singer Frances Black. 
(Ena Lynn)
 Contact the Family Support Network at 175 North 
Strand Road, Dublin 1. Tel: 01 836 5168 or email: 
sadietgrace@gmail.com
Frances Black at the Service of Commemoration and 
Hope (Photo: JJ Berkeley)
Members of the congregation at the service 
(Photo: JJ Berkeley)
Family Matters seminar
Ballymun Local Drugs Task Force hosted a policy seminar, 
Family Matters, on 21 October 2008. The aim was to explore 
key concepts, principles and practices in relation to addiction 
and the family with a view to infl uencing future development 
of drug and family policy.
Dr Paul Quigley outlined the evolution of methadone 
treatment in Ireland from a model focused on a quick detox in 
a central location followed by abstinence to one encompassing 
community-based clinics, with more GP involvement, 
partnership working and the inclusion of family members. He 
outlined the benefi ts of ‘home maintenance’, where family 
members are involved in dose supervision and risk reduction. 
Dr Paul McArdle discussed mental health and substance 
use in adolescents and described the infl uence of family 
structure and family relationships on young drug users. He 
said that mental health issues, especially conduct disorder, are 
important determinants of drug use among adolescents.
Dr Marguerite Woods spoke about the experiences of female 
drug users and their interactions with children, partners, 
families, drug treatment providers and social workers. Female 
drug users had varying degrees of success in preserving their 
role, identity and motherhood status, with some having lost 
all contact with their children. Women who had retrieved 
their motherhood role generally did so with the help of family 
members who had ‘held the fort’ and ‘kept social services 
away’. Some women suggested that family disapproval was 
greater for drug-using daughters than for drug-using sons, and 
a signifi cant number experienced a lack of family support or 
variations in support over time. Many women felt that asking 
for help made things more diffi cult for them in the struggle to 
preserve their motherhood roles. 
An audio-visual presentation portrayed the reactions of fathers 
to drug use and suggested that men are less likely to talk 
about what’s happening to them and often suffer in silence. 
Three concurrent workshops focused on drug use from 
a family perspective. Attendees also spoke of their own 
experiences and discussed a number of issues, including the 
lack of services and supports for siblings and partners of drug 
users, how best to inform drug users of available services 
and supports, and the length of time spent on methadone 
treatment. 
(Ita Condron)
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6On 24 September 2008 the fi rst annual reports on progress 
in relation to the Agreed Programme for Government 
2007–2012 were posted on the website of the Department 
of the Taoiseach.1 Progress in relation to drug- and alcohol-
related initiatives is noted in the reports by the departments 
of Community, Rural and Gaeltacht Affairs, Health and 
Children, and Justice, Equality and Law Reform. A summary 
of the main achievements, as reported, follows. 
Drug-free prisons 
An additional 155 prison staff have been appointed to allow 
for a drug-detection-dog service in the prisons, operational 
support units for search and intelligence gathering purposes, 
and enhanced security screening and searching of all 
persons entering prisons. Drug rehabilitation programmes 
for prisoners are being implemented with the support of 
specialist professionals such as nurses, psychologists and 24 
addiction counsellors. 
Drug Treatment Court 
The Department of Justice is examining the operation of the 
Court and offi cials are looking at best practice elsewhere to 
see how the Court’s throughput levels might be increased 
to the benefi t of recovering drug addicts and the wider 
community. 
Irish Sentencing Information System (ISIS) 
The feasibility of providing a computerised information 
system on sentences and other penalties imposed for 
criminal offences is being examined. An appropriate IT 
system has been developed, a pilot has been operating since 
June 2006 in Dublin Circuit Criminal Court, and a further 
pilot commenced in Cork Circuit Court in 2008. 
Mandatory sentencing
In the course of 2009 a mechanism will be introduced for 
undertaking a formal annual review of the effectiveness of 
the new stringent mandatory sentence regime for drug 
crime introduced in the Criminal Justice Act 2007.
‘Date rape’ drugs
The creation of a new offence of supplying and 
administering date rape drugs is being considered in the 
context of the current provisions of the Non-Fatal Offences 
Against the Person Act 1997. 
Treatment for cocaine users
Evidence shows that most cocaine users are polydrug users 
and need to be treated for polydrug misuse and not solely 
for cocaine use. Consequently, the HSE has re-oriented its 
addiction services to address the needs arising from the 
changing patterns of drug use in the population. The HSE is 
also involved in developing community-based, stand-alone 
stimulant intervention services. Evidence also indicates that 
many approaches already in use in general addiction services 
work well with cocaine users. Funding is being provided 
for measures at local and regional drugs task force level to 
strengthen and further develop initiatives aimed at tackling 
cocaine use in local communities. These include locally-
based awareness campaigns that dovetail with the HSE’s 
national campaign. 
Rehabilitation
The planning and development of a minimum of 25 
detoxifi cation residential beds recommended in the Drugs 
Rehabilitation report will be addressed by the HSE in 
conjunction with the recommendation contained in the HSE 
Report of the Working Group on Residential Treatment and 
Rehabilitation Services. Steps are being taken to increase the 
numbers on drug-specifi c community employment scheme 
places from 1,000 to 1,300. Funding is being provided for 
rehabilitation initiatives at local and regional drugs task 
force level, and funding for the Family Support Network is 
being increased.
Funding for community-based initiatives
Additional funding in 2008 was provided for the local and 
regional drugs task forces. Over 440 LDTF projects currently 
receive funding. Funding continued for the Premises 
Initiative Fund, and capital funding was also provided under 
the new Regional Youth Initiative, for the development of 16 
dedicated youth facilities in RDTF areas not covered under 
the Young People’s Facilities and Services Fund. 
Young People’s Facilities and Services Fund (YPFSF)
Current funding supports the employment of over 350 
youth and outreach workers, centre managers and 
administration staff, 24 sports development offi cers, and 
13 co-funded ‘Football in the Community’ development 
offi cers. Following announcements earlier in 2008, the YPFSF 
will be extended to Arklow, Athlone, Dundalk and Wexford, 
and arrangements to transfer responsibility for the fund to 
the Offi ce of the Minister for Youth Affairs and Children are 
being progressed. 
Alcohol-related disorder
The Intoxicating Liquor Act 2008 provides for measures to 
control alcohol-related disorder:
increased fi nes relating to alcohol-related disorder • 
and associated anti-social behaviour may be 
imposed;
a Garda member may confi scate alcohol from under-• 
18s in a public place; 
a Garda member may direct persons in possession of • 
alcohol in a public place to (a) surrender the alcohol, 
(b) desist from behaving in a disruptive manner, and 
(c) leave the area; and
the fi ne for supplying alcohol to • 
under-18s has increased from €1,500 
to €5,000. 
The Garda Síochána have identifi ed areas subject to anti-
social behaviour as hot spots, and additional foot and mobile 
patrols are directed to these areas during times when these 
offences are more likely to occur. 
Alcohol and good health 
Strengthened codes aimed at reducing the exposure of 
young people to alcohol advertising and marketing are due 
to come into operation soon. A Working Group to examine 
the extent of alcohol sponsorships and the terms and length 
of existing contracts is to be established. 
(Compiled by Brigid Pike) 
1. The Agreed Programme for Government 2007–2012 
and the annual reports for 2008 are all available in 
the Publications section of the ww of the Department 
of the Taoiseach at www.taoiseach.ie. For a summary 
of the Agreed Programme, see Galvin B (2007) Draft 
programme for government. Drugnet Ireland. (22): 1.
Agreed Programme for Government – 
progress report 2008
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The third bulletin of results from the 2006/7 all-Ireland 
general population drug prevalence survey1 (a follow-on 
from the fi rst such survey in 2002/32) focuses on cannabis 
use in the adult population (15–64 years) and patterns 
of cannabis use. The fi nal achieved sample was 4,967 in 
Ireland. This represented a response rate of 65%. 
This article highlights some of the survey fi ndings and 
presents unpublished data from the National Drug 
Treatment Reporting System (NDTRS), the National Drug-
Related Deaths Index (NDRDI) and Garda records.
Comparison of survey fi ndings 
Cannabis use increased over the four years between the 
two surveys. The proportion of adults who reported using 
cannabis at some point in their lives (ever used) increased 
from 17% in 2002/3 to 22% in 2006/7. The proportion of 
young adults who reported using cannabis in their lifetime 
also increased, from 24% in 2002/3 to 29% in 2006/7. 
The proportion of adults who reported using cannabis in the 
last year (recent use) increased from 5% in 2002/3 to 6% 
in 2006/7. The proportion of young adults who reported 
using cannabis in the last year increased from 9% in 2002/3 
to 10% in 2006/7. 
The proportion of adults who reported using cannabis in the 
last month (current use) remained stable at 2.6%.
Table 1 Lifetime, last-year and last-month prevalence of cannabis use in Ireland, 2002/3 and 2006/7 
Cannabis use Adults 
15–64 years (%)
Males 
15–64 years (%)
Females 
15–64 years (%)
Young adults 
15–34 years (%)
 2002/3 2006/7 2002/3 2006/7 2002/3 2006/7 2002/3 2006/7
Lifetime (ever used) 17.4 21.9 22.4 27.0 12.3 16.6 24.0 28.6
Last year (recent use) 5.0 6.3 7.2 8.5 2.9 3.9 8.6 10.4
Last month (current use) 2.6 2.6 3.4 4.0 1.7 1.1 4.3 4.2
Source: National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit 
(Bulletin 3, 2005 & 2008)
Practices among users – 2006/7 survey 
Those who had ever used: Half of all cannabis users had 
fi rst used the drug before they were 18 years old. The 
lifetime prevalence rate was higher for men (27%) than for 
women (17%). 
Regular users: Over one-quarter (26%) of respondents who 
had ever taken cannabis reported using (or having used) 
it regularly. The lag time between fi rst use and regular use 
was two years. Of those who were or had been regular 
users, two-thirds (66%) said that they had stopped taking 
cannabis, 10% said that they had tried to stop but failed and 
almost one-quarter (24%) had never tried to stop. Of those 
who had stopped, approximately one-third (32%) said they 
had done so because they no longer wanted to take the 
drug, 19% said they had health concerns and 17% said it 
was no longer part of their social life.
Recent users: The majority (62%) of recent cannabis users 
considered it ‘very easy’ or ‘fairly easy’ to obtain the drug 
within a 24-hour period. Over half (57%) reported obtaining 
the cannabis they had last used at the house of friends, 
12% obtained it in the street/park, 8% in a disco/bar/club 
and 5% ordered it by phone. The majority (44%) got the 
cannabis they had last used from a family member or friend, 
28% had shared it among friends and 22% had bought it. 
Current users: The majority (60%) of current cannabis 
users reported using a form of cannabis resin. Almost two-
in-fi ve (38%) reported using a form of herbal cannabis. 
Approximately 24% used the drug daily in the month prior 
to the survey, a further 10% used it several times a week, 
28% used it at least once a week and 37% used it less than 
once a week. Men were more frequent users than women. 
Almost all (99%) smoked it as a joint (93%), in a pipe (4%) 
or in a bong (3%): less than 1% ate the drug. 
NDTRS data
Analysis from the NDTRS indicates that the number of 
treated cases reporting cannabis as a main problem drug 
decreased from 1,384 in 2003 to 958 in 2007 (Table 2), of 
whom 74% used one or more additional drugs. The number 
of cases reporting cannabis as an additional problem drug 
increased from 1,383 in 2001 to 1,630 in 2007 (Table 
3). The drugs associated with cannabis use were alcohol, 
ecstasy, amphetamines and cocaine (Table 4). These data 
indicate that only a small proportion of cannabis users are 
seen at treatment services, and that the majority of those use 
more than one drug. Of the 958 cases treated in 2007 who 
reported cannabis as their main problem drug, 99% smoked 
it, and 1% ate it. Use by these cases in the month prior to 
treatment was reported as follows: 49% used it daily, 22% 
used it between two and six days per week, 8% used 
it once per week or less and 19% had not used it. As 
expected, the frequency of cannabis use among treated 
cases was considerably higher than that among the general 
survey population. 
Of these 958 cases, half had commenced cannabis use 
before they were 14 years old, and 86% were men. 
Of the total number, 109 (11%) lived in Dublin and 849 
(89%) lived elsewhere in Ireland. The numbers refl ect the 
greater availability of treatment for cannabis, cocaine and 
other non-opiate drugs in Dublin, rather than use among 
the general population. 
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Table 2 Cases entering treatment for cannabis as a main problem drug, 2001 to 2007
2001 2002 2003 2004 2005 2006 2007
Number (%)
All cases entering 
treatment
 
4797
 
4948
 
5054
 
4506
 
4877
 
5191
 
5684
Cases reporting 
cannabis as main 
problem drug
 
 
1136 (23.7)
 
 
1336 (27.0)
 
 
1384 (27.0)
 
 
991 (22.0)
 
 
1039 (21.3)
 
 
1096 (21.1)
 
 
958 (16.9)
Of whom:
New cases 781 924 955 736 794 809 694
Previously treated cases 299 349 401 224 219 260 255
Treatment status not 
known
 
56
 
63
 
28
 
31
 
26
 
27
 
9
Source: Unpublished data from the NDTRS
Table 3 Cases entering treatment who reported cannabis as an additional problem drug, 2001 to 2007 
2001 2002 2003 2004 2005 2006 2007
Number (%)
All cases reporting an 
additional problem drug
3459 3582 3760 3157 3401 3692 3816
Cases reporting 
cannabis as main 
problem drug
 
 
1383 (40.0)
 
 
1362 (38.0)
 
 
1445 (38.4)
 
 
1239 (39.2)
 
 
1417 (41.7)
 
 
1579 (42.8)
 
 
1630 (45.5)
Of whom:
New cases 540 511 556 449 527 583 681
Previously treated cases 797 797 842 757 844 925 904
Treatment status not 
known
 
46
 
54
 
47
 
33
 
46
 
71
 
45
Source: Unpublished data from the NDTRS
Table 4 Main problem drug and associated additional drugs used by new cases entering treatment, 2001 to 2007 
New cases 4708 769 1064 99 228 160 4999
Main problem drug
Opiates Ecstasy Cocaine Amphet-
amines
Benzo-
diazepines
Volatile 
inhalants
Cannabis
Additional problem 
drug(s) used*
 
Number (%)
Opiates 751 (16.0)† 16 (2.1) 78 (7.3) 1 (1.0) 36 (15.8) 2 (1.3) 128 (2.6)
Ecstasy 447 (9.5) 394 (37.0) 49 (49.5) 32 (14.0) 11 (6.9) 1897 (37.9)
Cocaine 1029 (21.9) 206 (26.8) 12 (1.1)† 25 (25.3) 37 (16.2) 3 (1.9) 865 (17.3)
Amphetamines 89 (1.9) 183 (23.8) 109 (10.2) 4 (1.8) 2 (1.3) 528 (10.6)
Benzodiazepines 1029 (21.9) 20 (2.6) 67 (6.3) 2 (2.0) 9 (3.9)† 1 (0.6) 117 (2.3)
Volatile inhalants 17 (0.4) 15 (2.0) 5 (0.5) 1 (1.0) 3 (1.3) 8 (5.0)† 118 (2.4)
Cannabis 1866 (39.6) 489 (63.6) 611 (57.4) 60 (60.6) 56 (24.6) 47 (29.4) 6 (0.1)†
Alcohol 466 (9.9) 341 (44.3) 497 (46.7) 36 (36.4) 103 (45.2) 57 (35.6) 2389 (47.8)
* By cases reporting use of one, two or three additional drugs. 
† Additional problem drug(s) used may be a form of drug in the same family as the main problem drug.
Source: Unpublished data from the NDTRS
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Cannabis use in Ireland (continued)
NDRDI data
According to data from the NDRDI, the number of poisoning 
deaths in which cannabis was implicated, alone or with 
another drug, was extremely small.3 
Garda data
Cannabis accounts for the majority of all drugs seized in 
Ireland. Of the 8,417 reported drug seizures in 2006, 4,243 
(50.4%) were of cannabis.4 The cannabis seizure data is in 
line with the use of cannabis among the general population 
prevalence data indicating that it is the most common illegal 
drug used in Ireland. 
(Jean Long)
1. National Advisory Committee on Drugs and Drug and 
Alcohol Information and Research Unit (2008) Drug 
use in Ireland and Northern Ireland. 2006/2007 drug 
prevalence survey: cannabis results. Bulletin 3. Dublin: 
National Advisory Committee on Drugs.
2. National Advisory Committee on Drugs and Drug and 
Alcohol Information and Research Unit (2005) Drug 
use in Ireland and Northern Ireland. 2002/2003 drug 
prevalence survey: cannabis results. Bulletin 3. Dublin: 
National Advisory Committee on Drugs.
3. Lyons S, Lynn E, Walsh S and Long J (2008) Trends in 
drug-related deaths and deaths among drug users in 
Ireland, 1998 to 2005. HRB Trends Series 4. Dublin: 
Health Research Board.
4. Alcohol and Drug Research Unit (2008) 2008 National 
Report (2007 data) to the EMCDDA by the Reitox National 
Focal Point. Ireland: new developments, trends and 
in-depth information on selected issues. Dublin: Health 
Research Board.
In January 2004, on foot of a modifi cation order to the UK 
Misuse of Drugs Act 1971 cannabis was reclassifi ed from a 
Class B to a Class C drug. The changes came about following 
a recommendation by the Advisory Council on the Misuse of 
Drugs (ACMD) in March 2002.
In January 2009, despite the opposition of the ACMD on this 
occasion, cannabis was again reclassifi ed as a Class B drug. 
Substances controlled under the Act are grouped on the 
basis of their harmfulness into three classes:
Class A•  (the most harmful) includes cocaine, heroin, 
ecstasy, LSD and methamphetamine
Class B•  (an intermediate category) includes 
amphetamine, barbiturates and, now, cannabis
Class C•  (less harmful) includes benzodiazepines and 
anabolic steroids.
This system of classifi cation helps determine the penalties for 
the possession and supply of controlled substances. 
In July 2007 the Home Secretary requested, in the light 
of ‘real public concern about the potential mental health 
affects of cannabis use, in particular the use of stronger 
forms of the drug, commonly known as skunk’, that the 
ACMD re-assess the classifi cation of cannabis.1 The ACMD 
reviewed the literature, particularly material published since 
2005, and considered oral and written evidence. In its 
published report, the Council concluded that ‘there are clear 
and obvious harms associated with the use of cannabis by 
people with psychotic disorders’ and that this was confi rmed 
by recent studies (p. 15). It also concluded that the evidence 
supports a ‘causal association between the use of cannabis, 
in adolescence, and the later development of schizophrenia’ 
(p. 18). The report refers to a recent study where ‘the 
authors concluded that the shift in cannabis consumption to 
more prolonged use, initiated at an earlier age, is relatively 
recent; and that its full impact may not yet be apparent’ (p. 
18). The ACMD remarked that while the causal link between 
cannabis use and psychotic illness was weak, ‘whether such a 
causal link will become stronger with the wider use of higher 
potency cannabis products remains uncertain’ (p. 30).
The ACMD reviewed the evidence on cannabis availability 
and purity and concluded that sinsemilla now dominates 
the UK cannabis market and that it appears to have a 
substantially higher tetrahydrocannabinol (THC) content 
than cannabis resin or traditional herbal cannabis. THC 
is the active ingredient which produces the sensation or 
‘high’ being sought by users. Sinsemilla is composed of 
the fl owering tops of unfertilised female cannabis plants 
produced by intensive indoor cultivation methods. Because 
of its greater potency, the ACMD expressed concern about 
the ‘substantial increase’ in the market share of sinsemilla. 
As part of its deliberations, the Council commissioned an 
opinion poll to investigate the views of the wider public 
on the classifi cation of cannabis. A majority of the 1,003 
respondents wanted cannabis to be classifi ed as a Class A 
or Class B substance. However, most did not favour the 
introduction of harsher penalties for cannabis possession, 
although this was the logical consequence of reclassifi cation. 
The ACMD made 21 recommendations to government, 
including that cannabis remain a Class C drug. In making 
this recommendation the Council stated: ‘Although the 
majority of members recognise the harms caused by the use 
of cannabis to individuals and society, they do not consider 
these to be as serious as those of drugs in Class B.’ However, 
the report also noted that: ‘A minority of members…remain 
very concerned about the effects of cannabis on the mental 
health of users, especially in the light of the (now) wide 
availability and use of sinsemilla. In their view the balance 
of harms more closely equates to substances in Class B than 
Class C’ (p. 34). The ACMD agreed to conduct a further 
review of the evidence in 2010.
The government accepted 20 of the 21 recommendations 
of the ACMD. These covered areas such as primary and 
secondary prevention, supply reduction, measures to protect 
particular at-risk groups, and further research. In rejecting 
the ACMD’s recommendation on the classifi cation of 
cannabis and in justifying its decision to reclassify cannabis 
as a Class B drug, the government stated: ‘Government 
is expected to take an overview…we have to maintain a 
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HSE outlines plans for drug and alcohol 
services in 2009 
classifi cation for cannabis that takes account of its known 
risks to health as well as the potential long-term impacts on 
health where the evidence is not conclusive. The signifi cant 
increase in both the market share of higher than average 
potency cannabis and its actual potency in the last few years 
in the UK are compelling factors.’2 
As a Class B drug, the maximum penalty for supplying or 
producing cannabis is 14 years’ imprisonment and/or an 
unlimited fi ne. This remains unchanged from when the drug 
was Class C. However, with reclassifi cation, the maximum 
penalty for possession increases from two to fi ve years’ 
imprisonment. The government also intends to introduce an 
‘escalation’ penalty system for cannabis possession by those 
aged over 18. The system for under-18s caught in possession 
will remain unchanged as it already provides an escalation 
mechanism, according to the government’s response. 
(Johnny Connolly)
1. Advisory Council on the Misuse of Drugs (2008) 
Cannabis: classifi cation and public health. London: United 
Kingdom Home Offi ce. Available at: http://drugs.
homeoffi ce.gov.uk/publication-search/acmd/acmd-
cannabis-report-2008?view=Binary
2. Central Offi ce of Information (2008) Government 
response to the recommendations made by the Advisory 
Council on the Misuse of Drugs in its report Cannabis: 
classifi cation and public health. London: Central Offi ce 
of Information (COI) on behalf of HM Government, p. 2. 
Available at: 
http://drugs.homeoffi ce.gov.uk
The Health Service Executive’s National Service Plan 2009 
(NSP) contains the agency’s plans in the drugs and alcohol 
area during 2009.1 HSE Addiction Services, including both 
illicit drugs and alcohol, are delivered as part of Social 
Inclusion Services, which, in turn, are part of the Primary, 
Community and Continuing Care (PCCC) directorate. 
The table below summarises the key result areas for 2009 
together with the outputs delivered in 2008 and the 
deliverables for 2009. 
‘Key result areas’ are a new element in the HSE’s annual 
service plan. They have resulted in a rationalisation and 
reduction in the number of action lines in the addiction 
services area. Just three key result areas are identifi ed: 
enhancement of addiction services, development of the 
National Drugs Strategy, and the mainstreaming of health-
related drugs task force projects.2
Addiction Services in 2009 (after HSE NSP 2009: 49)
Key result area Output 2008 Deliverable 2009
Enhancement of addiction services
(Progress implementation of the 
recommendations of the 2007 report 
of the Working Group on Drugs 
Rehabilitation.)
Regional addiction plans developed
Recruitment of Rehabilitation 
Co-ordinator under way
Development of National Rehabilitation 
Implementation Committee under way
Further development of multi-
disciplinary teams for provision of 
services to under-18 year-olds. 
This will facilitate the further 
development of harm reduction 
services, including needle exchange 
and methadone services. 
Implementation of the Rehabilitation 
Strategy (to include appointment of 
co-ordinator)
Development of new National Drugs 
Strategy (NDS)
HSE / Department of Health and 
Children submission to NDS review.
Planning undertaken for 
implementation of HSE components 
of the new National Drugs Strategy 
2009 – 2013 
National Drugs Task Force Mainstreaming process agreed with 
the Departments of Community, Rural 
and Gaeltacht Affairs and Health and 
Children
Progression of mainstreaming of 
169 local drugs task forces (LDTFs) 
as appropriate, starting from April 
onwards.
The performance information framework used in the HSE 
has also been refi ned. In the addiction services area, one 
measure of ‘activity’ and two indicators of ‘performance’ 
have been identifi ed. The fi gures indicate that, nationally, 
the level of activity in the addiction services area increased 
in 2008 and this new level is due to be maintained in 2009, 
but the level of performance is expected to remain static at 
2007 levels. The 2009 performance target for treatment of 
substance misusers aged under 18 is based on baseline data 
collected in 2008. 
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British–Irish Council meeting on drug 
misuse 
On 20 November 2008 the British–Irish Council’s Misuse of 
Drugs Sectoral Group held a Ministerial meeting.1 Chaired 
by Ireland’s Minister of State with responsibility for drugs 
strategy, John Curran TD, the meeting focused on how 
to engage effectively with communities regarding drug 
use. The ministers agreed that engaging communities 
and developing community-based responses can make a 
signifi cant contribution in dealing with the issue of problem 
drug use in society. Although different administrations are 
developing their own approaches, the ministers were of the 
view that sharing experiences provides a good opportunity 
for learning from each other. They resolved to continue 
to co-operate and exchange experiences, with particular 
emphasis on initiatives that have led to successful outcomes 
and that may lend themselves to broader application in 
other administrations. 
The ministers reviewed the work carried out by the Sectoral 
Group during 2008: 
Ireland hosted the tenth BIC Summit when the  ■
topic of ‘Families and drugs misuse – challenges and 
opportunities’ was discussed; 
Northern Ireland hosted an expert seminar presented by  ■
Professor J David Hawkins (Seattle) on the topic ‘Using 
advances in prevention science to guide substance 
misuse prevention in communities’; and 
Jersey hosted a meeting on ‘Engagement of young  ■
people with substance misuse’. 
The ministers agreed that work in 2009 will focus on the 
following areas:
Guernsey will host a meeting on substance issues  ■
in prisons; 
Ireland will host a meeting on drug deaths indices; ■
Scotland will host a meeting on a topic for discussion yet  ■
to be fi nalised: and 
Isle of Man will host the next Ministerial meeting in  ■
late 2009. 
These meetings will also seek to strengthen and consolidate 
the ongoing co-operation and the exchange of information, 
experience and best practice between members. 
(Brigid Pike)
1. For further information on the British–Irish Council 
and the work of its Misuse of Drugs Sectoral Group, visit 
www.britishirishcouncil.org 
HSE plans for drug and alcohol services (continued)
Activity – the average number of clients in methadone • 
treatment per month per area: In 2008 the national 
target was to maintain throughput at the 2007 level 
of 7,000 clients. In the event, throughput in 2008 
reached 7,636 and the HSE expects to reach this 
level of activity again in 2009. 
Performance – the number and percentage of substance • 
misusers for whom treatment, as deemed appropriate, 
commenced within one calendar month: In 2008 the 
national target was to exceed the 84% (n=1,406) 
performance level achieved in 2007. In the event, 
the 2007 level was attained but not exceeded, and 
this same level of 84% has been set as the target 
for 2009.
Performance – the number of substance misusers • 
under 18 years of age for whom treatment, as deemed 
appropriate, commenced within one calendar month: 
No target was set for this indicator in 2008 as the 
staff to develop services for under-18s were only 
appointed during 2008. However, data collected 
in 2008 showed that 88% (n=106) of substance 
misusers under the age of 18 commenced 
suitable treatment within a calendar month. 
This performance level has been set as the target 
for 2009.
The breakdown of performance by HSE region, also 
published in the plan, reveals variations, with the 
regions around Dublin performing below par. Regarding 
commencement of treatment for substance misusers 
in 2008, the Southern Region exceeded the national 
target by over 10% at 96% (n=547), while the combined 
Dublin/North East and Dublin/Mid-Leinster regions only 
achieved a performance level of 64% (n=510). Regarding 
commencement of treatment for under-18s, the target 
timeframe of one calendar month was achieved 100% by 
both the Southern (n=53) and Western (n=30) regions, but 
the combined Dublin/North East and Dublin/Mid-Leinster 
regions only achieved a level of 62% (n=23). These regional 
performance targets have been rolled over for 2009. 
Under the heading of ‘Improving our infrastructure’, the 
service plan lists two capital works in the Dublin/Mid-
Leinster Region, which, it states, are to be commissioned and 
in place before the end of 2009 and which can be funded 
within the HSE’s 2009 allocation:
Clondalkin:•  new purpose-built addiction centre 
providing psychiatry, GP, counselling, pharmacy, 
nursing, psychology and family therapy services; and 
Pearse Street:•  refurbishment and upgrade of the Drug 
Treatment Centre. 
(Brigid Pike)
1. Health Service Executive (2008) National Service Plan 
2009. Available at www.hse.ie 
2. For accounts of previous HSE Service Plans, see B Pike 
(2007) HSE outlines plans for drug-related services in 
2007. Drugnet Ireland. (22): 5–7; B Pike (2008) HSE 
outlines plans for drug and alcohol services in 2008. 
Drugnet Ireland. (25): 9–10. 
3. According to the discussion on the measurement and 
monitoring of performance contained in the National 
Service Plan 2009, the performance indicators contained 
in the plan will be reported in the HSE Performance 
Monitoring Reports (PMRs), which are due to be 
produced monthly, quarterly, bi-annually and annually. 
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Review of the evidence base in 
drug prevention
This article summarises the main conclusions 
drawn in a recent review of the evidence base 
in substance abuse prevention published by the 
European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA).1 It will focus in particular on 
family- and school-based prevention as these are 
important areas of intervention in Ireland’s National 
Drugs Strategy. 
The review included 49 studies, including 
eight meta-analyses, 22 systematic reviews, 13 
unsystematic reviews, four best-practice surveys 
and two other publications. These studies 
were systematically identifi ed from searches 
of established databases, e.g. the Cochrane 
Library, PubMed and PsychInfo. Two assessors 
independently rated the studies by content and 
method using a coding system. They then jointly 
formulated their conclusions and rated them for 
strength of evidence from A to F, according to 
whether they were based on:
A – a meta-analysis involving high-quality studies 
B – a systematic review involving high-quality 
studies 
C – a meta-analysis or systematic review covering 
all relevant studies 
D – an unsystematic review 
E – a discussion or an individual study or conclusion 
on the basis of empirical results 
F – a contradictory body of evidence from reviews 
in different categories.
Family-based prevention: conclusions from the 
evidence base
What works 
Comprehensive family-orientated approaches 
(training for parents, children and families) have 
preventive effects on consumption behaviour in 
relation to alcohol. The studies included did not 
focus on preventing illicit drug use. 
Family-orientated measures are particularly effective 
with non-consumers (of alcohol), particularly the 
parents. 
Parental training alone can infl uence risk factors 
(increasing pro-social behaviour) but not 
consumption of substances. 
How it works 
Parental training includes a focus on developing 
basic educational behaviour (use of discipline, 
supervision and problem-solving techniques) and 
on fostering parent–child relationships, as well as 
on parental commitment to the child’s schooling. 
Training involving children teaches ways to resist 
peer offers of substances for consumption, social 
problem-solving abilities, confl ict management and 
learning skills. 
Engaging hard-to-reach families 
Measures to involve hard-to-reach families 
appear successful (Strategic Structural Systems 
Engagement approach) 
Strength of evidence for family-based prevention 
Rated C and D. While there were numerous 
random controlled trials included in the reviews, 
there were no reviews of high-quality studies and 
no meta-analyses. 
School-based prevention: conclusions from the 
evidence base
What works 
Interactive school-based programmes have 
preventive effects on consumption behaviour for 
tobacco, alcohol, cannabis and other illicit drugs. 
School-based programmes that implement the 
concepts of social infl uence and life skills are 
effective, and equally so for all substances. 
Effects with regard to alcohol and tobacco can be 
long term (2–3 years)
School-based prevention programmes have less 
effect on consumption behaviour than they do on 
risk factors such as dropping out of school, truancy 
and other problem behaviour. 
Short-term effects are a good pointer to long-term 
effectiveness. 
What does not work 
Non-interactive programmes are not effective; 
such programmes include information provision 
alone, emotional education alone, transmission 
of values and decision-making alone and DARE-
type programmes (delivered didactically by police 
offi cers in the United States). 
Strength of evidence for school-based prevention 
Rated A to C. The report reviewed numerous meta-
analyses including high-quality studies. 
Disseminating information on what works in drug 
prevention is an important fi eld of interest for the 
EMCDDA. Currently this work is done through 
the best practice portal of the EMCDDA2 where 
a number of reviews are stored. The Alcohol and 
Drug Research Unit of the Health Research Board 
(HRB), as the Focal Point for the EMCDDA in 
Ireland, is committed to summarising these reviews 
for the benefi t of our stakeholders in Ireland and 
disseminating this information. Commentary on a 
review of the evidence base for selective prevention 
targeting high-risk groups will be covered in a 
future issue of Drugnet Ireland. 
(Martin Keane)
1. Bühler A and Kröger C (2008) EMCDDA 
Insights: Prevention of substance abuse. 
Luxembourg: Offi ce for Offi cial Publications of 
the European Communities. First published in 
German in 2006 as Expertise zur Prävention des 
Substanzmißbrauchs by the Federal Centre for 
Health Education and subsequently translated 
into English by the EMCDDA. 
2. http://www.emcdda.europa.eu/themes/best-
practice 
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Tony Gregory 1947–2009 – an 
appreciation 
Tony Gregory TD passed away on 2 January of this year, after 
a short battle with stomach cancer. Tony was fi rst elected 
to Dublin City Council in 1979 and he won his Dáil seat in 
1982. His name immediately became recognised nationally 
as the so-called ‘Gregory deal’ brought Charles Haughey 
and Fianna Fáil to power. The fall of Haughey’s government 
within the year meant that the deal never fully bore fruit, 
with its promise of 500 local houses and 3,000 jobs, as well 
as the nationalisation of a 27-acre site in Dublin’s docklands. 
However, Tony’s tireless advocacy over the next 20 years 
on behalf of his constituents in Dublin North Central would 
see him returned to the Dáil in every subsequent election 
until his untimely death, a feat never before achieved in the 
history of the state by an independent politician. 
In a constituency with a very low electoral turnout and 
one of the highest levels of socio-economic deprivation 
in the state, Tony’s focus was on the issues of poverty, 
unemployment, education and housing. The added scourge 
of drug dealing and the attendant misery it brought to 
the community of which he was a part would ensure that, 
over the next three decades of public life, his name would 
become synonymous with confronting this issue. On one 
occasion he bravely named a number of local drug dealers 
in Dáil Éireann. On another, as he questioned why more 
of these dealers were not being jailed, he went to prison 
himself in defence of the treatment of street traders who 
were bringing one of the few sources of legitimate income 
into his constituency.
Tony was an extremely private person and he did not 
welcome intrusion into his personal affairs. In one of his last 
political battles he won a Press Council ruling against the 
Evening Herald for breach of privacy, after a reporter and 
photographer visited his Ballybough home in search of a 
story about his illness.
I began working with Tony in a professional capacity in 
the late 1990s as an advisor on the setting up of the North 
Inner City Community Policing Forum. To say he was a joy 
to work with would perhaps be a poor choice of words. 
He had a healthy scepticism about so-called ‘advisors’ and 
his standards were exacting. Whatever about his ‘bite’, his 
‘bark’ was generally enough to ensure that few mistakes 
were made and that none were repeated. Working with 
him on other issues since that time, I came to realise that 
this was how he delivered on the mandate he received at 
the polls and I respected him immensely for it. He applied 
an incredible intensity to the work at hand, whether it was 
reading a mundane report or preparing a parliamentary 
question. His work rate was phenomenal and, although he 
had loyal comrades who worked with him throughout his 
Dáil career, he never took his position for granted, always 
highlighting the extra challenge facing an independent 
against the party machines come election time.
I heard of Tony’s untimely passing during a holiday on 
Inis Meáin, one of the Aran Islands. As we all watched the 
news of his death on RTÉ, the esteem in which he was 
held even in that remote part of the country was palpable. 
As his legacy was discussed through the medium of the 
Connemara gaeltacht, I wondered how many were aware of 
his background as a teacher in Coláiste Eoin in south Dublin 
and his grá for the language, refl ected in his request that his 
funeral mass be delivered primarily through Irish.
Having worked in recent years with Tony and others in 
relation to community policing, the fi nal impression left 
after his funeral was the huge Garda presence and the effort 
that was put by An Garda Síochána into ensuring that the 
occasion attended by thousands passed off smoothly. It was 
clear to me and others that the gardaí had pulled out all the 
stops as a mark of respect for him, never one of their biggest 
cheerleaders. Tony was above all a servant of his community, 
and he saw it as their entitlement that his constituents 
received nothing less than the service to which they are 
entitled. Ní bheidh a leithéad arís ann.
(Johnny Connolly)
Tony Gregory 1947–2009 (Photo: JJ Berkeley)
Substance use among Ireland's children 
On 9 December 2008 the Minister for Children and Youth 
Affairs, Chris Andrews TD, launched State of the nation’s 
children: Ireland 2008 (SONC 2008).1 As with the fi rst report, 
published in 2006, the 2008 report presents key indicators 
on aspects of children’s lives, including outcomes on their 
education, health and social, emotional and 
behavioural well-being; their relationships with their parents 
and their friends; and the services available to and accessed 
by them. 
(Brigid Pike) 
1. Offi ce of the Minister for Children and Youth Affairs 
(2008) State of the nation’s children: Ireland 2008. Dublin: 
Stationery Offi ce. Retrieved on 21 January 2009 at 
www.omc.gov.ie
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Alcohol Implementation Group report 
2008 
Ms Mary Wallace TD, Minister for Health Promotion and 
Food Safety at the Department of Health and Children, 
published the Social Partnership Alcohol Implementation 
Group (AIG) report in December 2008.1 This group 
was formed to monitor and report on progress on the 
implementation of the actions contained in its report, 
Working together to reduce the harms caused by alcohol 
misuse.2 The group comprised social partners and relevant 
government departments and agencies, and agreed a 
programme of 29 actions to deliver targeted results in 
relation to underage drinking, binge drinking and drink 
driving. 
The main actions and progress to date are outlined below. 
Actions Progress to date
Local community responses
Establish 4–6 community mobilisation projects (CMPs) ■ Nineteen grants totalling €1,061,955 were awarded to 
community-based projects to tackle alcohol misuse. The AIG 
is disappointed that the envisaged number of multi-agency 
CMPs have not been established.
Treatment intervention services
Establish pilot screening and brief intervention (SBI)  ■
programmes and protocols in healthcare settings
The HSE is introducing systems whereby alcohol-related 
data collection and SBI can be put in place in all acute 
hospitals, and is developing protocols for the roll-out of SBI 
programmes on a pilot basis in some acute hospitals. 
Awareness and education
Continue roll-out of the Social, Personal and Health Education  ■
(SPHE) programme in schools
Develop education initiatives in out of school settings ■
Increase training on alcohol issues for community/youth  ■
workers
Increase public awareness through local media campaigns ■
The SPHE is a compulsory part of the junior cycle 
programme and a SPHE curriculum for senior cycle students 
has been fi nalised. The Department of Education and 
Science intends to establish a working group to develop 
guidelines for implementing programmes in non-school 
settings. The HSE ran a public information campaign on 
underage drinking in 2008 and the drinks industry has 
committed to providing funding of €20 million to promote 
responsible alcohol use. 
Alternative facilities
Promote and develop alcohol-free recreational facilities ■
Promote responsible approaches to alcohol by sporting  ■
organisations
In 2007, €1.12 million was allocated to provide recreational 
and personal development opportunities for disadvantaged 
young people. The national recreation policy,Teenspace, 
was launched in 2007 and provides a strategic framework 
for the promotion of positive recreational opportunities. The 
HSE has developed partnerships with the GAA and the FAI to 
address alcohol-related harm though policy and action.
Compliance and enforcement
Promote responsible serving of alcohol (RSA) and trading  ■
programmes
Improve security for National Age Card to prevent forgery ■
Develop early intervention within the justice system ■
In 2007 a working group was established to review the 
effectiveness of RSA programmes. The National Age Card 
regulations are in place and the new card contains security 
features to prevent forgery. In 2007, 29 new Garda youth 
diversion projects were announced and 12 new projects are 
expected in 2008; €11.909 million has been allocated for 
these projects in 2008.
Workplace
Develop guidelines for workplace alcohol policy ■ The HSE is working with IBEC and ICTU to develop and 
publish these guidelines.
Below-cost selling
Prohibit below-cost selling ■ The AIG is hopeful that the report of the Alcohol Advisory 
Group will lead to progress on this issue.
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AIG report (continued)
Off-trade
Develop a code of practice with the off-trade sector ■ This process is being led by the Minister for Justice, Equality 
and Law Reform following enactment of the Intoxicating 
Liquor Act 2008.
Alcohol advertising
Consider further representation from social partners on  ■
alcohol monitoring body
Introduce a 9pm watershed for alcohol advertising ■
Strengthened codes of practice have been accepted and 
came into effect in 2008. Some social partners expressed the 
view, however, that legislation was preferable to voluntary 
codes as a means of protecting young people.
Drink driving
Introduce random breath testing ■
Reduce blood alcohol concentration (BAC) limit for drivers to  ■
0.05% (50mg per 100ml)
Review lowering of BAC limit for provisional drivers ■
Random breath testing was introduced in 2006 and led to 
a decrease in road fatalities in 2007. The current road safety 
strategy identifi es the need to reduce the legal BAC level and 
the government has accepted this recommendation. 
Labelling
Establish group to consider what information to include on  ■
non-draft alcohol products
The AIG recommends that mandatory information be shown 
on labels, including the amount of alcohol in the container 
and the dangers of alcohol consumption in pregnancy. 
The AIG had mixed views on the progress achieved in 
implementing the actions, and some partners expressed 
concern that the present group had a narrow focus and 
did not encompass the broad range of recommendations 
contained in the Strategic Task Force on Alcohol report. 
However, it was agreed that a remit to monitor and seek 
implementation of a smaller number of actions would 
improve the possibility of progress in the area, and 
establishing a small number of broadly based community 
mobilisation projects was considered a very worthwhile 
initiative by the group. 
(Deirdre Mongan) 
1. Department of Health and Children (2008) Report of the 
implementation group on alcohol misuse. Dublin: DOHC.
2. Department of Health and Children (2006) Sustaining 
Progress special initiative: working together to reduce the 
harms caused by alcohol misuse. Dublin: DOHC.
Alcohol pricing and promotion
A recent report commissioned by the Department of Health 
in the UK has analysed the effects of alcohol pricing and 
promotion polices on alcohol-related consumption and, by 
extension, on health, crime, workplace absenteeism and 
unemployment to help government decide future alcohol 
policy.1 The research team at the University of Sheffi eld 
analysed over 40 separate policy scenarios to examine how 
policies affect alcohol purchasing and consumption by 
different population groups, including moderate, hazardous, 
harmful and underage drinkers, both in the on-trade and 
off-trade sector.
The main effects of different policy measures are 
summarised below.
The effects of introducing across-the-board 
price increases
Across-the-board price increases covering all products in 
the on-trade and off-trade can have a substantial impact on 
reducing consumption and harm. Such price increases mean 
that there is less incentive for consumers merely to switch 
between different types of alcohol or drinking venues, unlike 
price increases targeting certain products or market sectors. 
Across-the-board price increases tend to lead to relatively 
larger reductions in mean consumption than other pricing 
options. Policies that specifi cally target low-priced products 
or certain product categories lead to smaller changes in 
consumption, as they only cover a part of the market.
The effects of introducing minimum pricing
Harmful drinkers tend to buy alcohol that is cheaper than 
that bought by moderate drinkers. Cheap alcohol is also 
attractive to young people. A minimum price policy might 
be considered benefi cial in that it targets the drinkers 
causing the most harm to both themselves and society 
while having little effect on the spending of adult moderate 
drinkers. Increasing levels of minimum pricing show a very 
steep increase in effectiveness; for example, a 20p minimum 
unit price would lead to a 0.1% reduction in consumption, 
while a 70p minimum unit price would lead to an 18.6% 
reduction. Minimum prices targeted at particular types of 
drink are less effective than all-product minimum prices. 
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The effects of banning off-trade price promotions 
Just over 50% of all alcohol purchased from supermarkets in 
the UK is sold on promotion. Only quite tight restrictions on 
the level of discount offered would have noticeable policy 
effects. Banning only buy-one-get-one-free offers has very 
little effect on alcohol consumption and harm. A total ban 
on off-trade discounting is estimated to reduce consumption 
by 2.8%, although this may prove effective only if retailers 
are prevented from reacting to the ban by simply lowering 
their non-promotional prices.
The effects of banning alcohol advertising
There is some uncertainty over the mechanisms linking 
advertising to consumption, and it is unclear whether 
advertising restrictions can be expected to have an 
immediate effect on consumption. The international 
evidence suggests that the effects of advertising may be 
cumulative over time, and may work by infl uencing attitudes 
and drinking intentions, rather than by directly altering 
consumption levels. 
The effects of these policies on alcohol-related harm
In 2008 the cost of alcohol misuse in England was 
estimated to range between £17.7 and £25.1 billion, which 
corresponds to £346–£491 per head of population. The 
general pattern observed in this report is that the more 
restrictive the policy, the greater the harm reduction. Higher 
minimum unit prices lead to greater harm reduction.
As prices increase, alcohol-attributable hospital admissions 
and deaths are estimated to reduce, the reduction in deaths 
occurring disproportionately among harmful drinkers. 
The health harm reductions are mostly related to chronic 
diseases rather than to acute conditions such as injuries. 
This is because much of the alcohol-attributable health 
harm occurs in middle or older age groups at signifi cant risk 
of developing or dying from chronic disease. In addition, 
policies resulting in bigger price increases reduce deaths 
in moderate and hazardous drinkers. In terms of hospital 
admissions, policy options that increase prices for only a 
proportion of products and by marginal amounts have very 
small effects.
Crime harms are estimated to reduce as prices are increased. 
Reductions take place across the spectrum of violent crime, 
criminal damage and theft, robbery and other crimes. A 
minimum unit price of 30p is estimated to reduce total 
crimes by around 3,800 per year, whereas at 40p the 
reduction is estimated at 16,000. Crime harms are estimated 
to reduce particularly among 11–18-year-olds as they are 
disproportionately involved in alcohol-related crime and are 
signifi cantly affected by price rises in low-priced products. 
In general, all policy options that target harmful and 
hazardous drinkers are effective in reducing alcohol-related 
harm in the workplace. The size of the effect is dependent 
on the extent of the price increase. Unemployment due to 
alcohol problems occurs mainly in the harmful drinker group 
and is estimated to reduce as prices increase; for example, 
3,800 avoided unemployment cases per annum in response 
to a minimum unit price of 30p, compared to 12,400 for a 
40p minimum. 
In conclusion, pricing policies can be effective in reducing 
health, crime and employment harms and these policies can 
be targeted so that those who drink within recommended 
limits are minimally affected and very heavy drinkers, who 
are responsible for the majority of alcohol-related harms, pay 
the most. 
(Deirdre Mongan)
1. Meier P, Brennan A, Purshore R, Taylor K, Rafi a R, Booth 
A et al. (2008) Independent review of the effects of alcohol 
pricing and promotion: Part B. Modelling the potential 
impact of pricing and promotion policies for alcohol in 
England: Results from the Sheffi eld alcohol policy model, 
Version 2008(1-1). Sheffi eld: University of Sheffi eld.
Alcohol pricing and promotion (continued)
Maggie Bowen – an appreciation
Staff and clientele at Rialto Community Drug Team (RCDT) 
were given the very sad news of the death of Maggie Bowen 
on 22 December 2008 after a relatively short period of 
illness. The RCDT was set up in late 1992 and within three 
years we were joined on our team by Maggie. It was her fi rst 
post as an addiction counsellor, being seconded to us by the 
then Eastern Health Board.
There is much talk these days about ‘target indicators’ and 
‘value for money’. Her clientele expressed a profound sense 
of devastation, sadness and loss. They told about how she 
touched their lives and helped them to make changes and 
move forward. These were very eloquent and touching 
testimony of how her work and input made a huge and 
incalculable and qualitative difference to so many individuals 
and families in this part of the city and sadly capture in a 
dramatic and personal manner the value of building trusting 
relationships that all the statistics in the world can only 
hint at. 
Maggie played a major part in helping to develop the broad 
range of services in our drug team. She particularly put 
a lot of time and effort into building up our community 
methadone satellite clinics and was to the fore in ensuring 
that the treatments did not stop with methadone only. 
She conscientiously developed her counselling skills and 
knowledge over the years. She built on her Trinity diploma 
course by doing a psychotherapy degree and a specialised 
course on cognitive behaviour therapy. Her work in helping 
others to grow was matched by her commitment to her own 
personal growth.
Our team is now doing its best to cope with its great loss. 
We send our love to her son, Russell and to her mother and 
brothers in Wales.
We held a ‘Month’s Mind’ for Maggie in our Centre at 
the end of January. Clients, family, friends and colleagues 
attended the service, which included the dedication of the 
‘Maggie Bowen Counselling Room’. It can be truly said of 
Maggie – Ní bheidh a leithéid arís ann (her likes will never be 
here again). 
(Rialto Community Drug Team)
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Assessment of early interventions for 
at-risk youth 
This article reports fi ndings from a recent Rapid Evidence 
Assessment (REA) of effective early interventions for youth at 
risk of future poor outcomes.1 The REA is a review of reviews 
including systematic reviews and meta-analysis. This review 
had two objectives: (1) to identify the risk factors related to 
poor outcomes, and (2) to identify the interventions that work 
to reduce these risk factors and improve outcomes. This article 
will focus on the review fi ndings in relation to risk factors 
and effective interventions for alcohol and drug use among 
13–19-year-olds. 
Review fi ndings on risk factors
The review identifi ed risk factors in four areas, as shown in 
Table 1 below. 
Table 1 Risk factors associated with alcohol and drug use 
Family risk factors School risk factors Individual and peer 
risk factors
Community risk factors
Poor parental discipline 
Weak family cohesion 
Parental drug and alcohol use 
Parental attitudes to drugs 
Poor parental monitoring and 
supervision 
Sibling drug use 
Sibling sources of drug supply 
Siblings co-drug-users 
Early-life trauma 
Family breakdown and mode 
of family interactions 
Low income and poor housing 
Experience of authority care 
Low achievement at school 
Lack of commitment 
(absences, truancy) 
School exclusions 
Non-compliance with school 
rules 
Lack of educational 
attainment 
Truancy (when experienced 
during middle childhood, 
9–11 years, and adolescence, 
12–18 years)
Personal attitudes 
condoning problem 
behaviour (malleable) 
Friends involved in 
problem behaviour during 
adolescence (malleable) 
Poor self-esteem and 
depression (malleable) 
Age (fi xed) 
Gender (fi xed) 
(female school truants more 
likely to abuse than males) 
Ethnic background (fi xed)
Drug availability 
Exposure to drug-using 
peer groups Increased 
chance of being targeted as 
new consumer
Source: Adapted from Thomas et al. 2008 
Review fi ndings on effective interventions
Behaviour therapy, culturally sensitive counselling in • 
residential settings, family therapy, and the 12-step 
Minnesota programmes were most successful in 
reducing drug use.
Family therapy was most successful in reducing • 
psychological problems of young drug users. 
Family therapy, family teaching, non-hospital day • 
programmes, residential care services, and school-
based life-skills interventions were most successful in 
improving family and social outcomes.
Drug education was associated with lower drug use; • 
however, the interventions had only a small impact 
and the gains dissipated over time.
School-based life-skills training programmes had some • 
success in preventing drug use in high-risk subgroups; 
success rates improved when 
targeted interventions were nested within the universal 
programmes.
Strengths and weaknesses of this review
This is a wide-ranging review of the literature, covering 
many topic areas and, because its conclusions are based on 
systematic reviews, the evidence behind its fi ndings can, 
on the whole, be considered to be high quality and robust. 
However, the authors advise caution in interpreting the 
fi ndings for two reasons. First, while the vast majority of 
studies reviewed show correlations between risk factors and 
poor outcomes, the results do not usually justify the inference 
of a causal link between a given risk factor and an outcome. 
Second, an intervention which works for one group of clients 
may have no comparable effect on another group because of 
moderating variables that may be present, e.g. genetic factors.
Discussion
Eleven reviews were identifi ed which targeted alcohol and 
drug use. Many of these reviews included multi-component 
interventions delivered in a range of settings, including school, 
community, and family. The vast majority of interventions 
operate at the individual or family level. According to the 
authors, this may refl ect the greater importance of these levels 
in determining behaviour. Equally, this may refl ect the greater 
emphasis placed on individualism and personal responsibility 
by policymakers and scientists alike. The fi ndings suggest that 
multidimensional family therapy and cognitive-behavioral 
group treatment are effective in reducing risk factors among 
at-risk youth. This is an interesting fi nding as it suggests 
that group-based interventions may be more effective in 
responding to the needs of at-risk youth than interventions 
targeted at the individual. 
(Martin Keane) 
1. Thomas J, Vigurs C, Oliver K, Suarez B, Newman M, 
Dickson K and Sinclair J (2008) Targeted youth support: 
Rapid Evidence Assessment of effective early interventions 
for youth at risk of future poor outcomes. In Research 
Evidence in Education Library. London: EPPI-Centre, Social 
Science Research Unit, Institute of Education, University of 
London.
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The process of youth homelessness
A report on Phase II of a qualitative longitudinal study on 
homelessness among young people in Dublin city was 
published in 2008.1 The research adopted a pathways 
approach that aimed to generate in-depth understanding of 
the process of youth homelessness, with particular focus on 
movement into, through and out of homelessness. 
Research methods
Phase II data were collected between September 2005 
and August 2006. Information was successfully obtained 
about the living situations of 37 of the 40 young people (23 
males and 17 females) recruited in Phase 1,2 and follow-
up interviews were conducted with 30 (16 males and 14 
females). The life history interview was the main method of 
data collection and young people were asked to ‘update’ 
their life history narrative by detailing signifi cant events since 
the time of their initial interview.
Findings 
In analysing the narratives of the 30 young people re-
interviewed at Phase II, the researchers were able to 
categorise three pathways:
Independent exits from homelessness• 
Dependent exits from homelessness• 
Continued homelessness• 
Independent exits
Six of the young people had moved home and one had 
moved to private rented accommodation. Those who had 
continued contact with and support from their families 
throughout the homeless experience made a smoother 
transition home and were more likely to view their move 
home in positive terms. Among those for whom drug use 
was an issue, continued family and parental support was 
almost always contingent on the young person seeking drug 
treatment and quitting use. This often involved breaking ties 
with past friends and associates within both street and drug 
scenes and establishing new social networks.
Dependent exits 
Ten of the young people had either moved to transitional/
supported housing (n=7) or to a residential care setting 
(n=3). They were helped to make this move by support 
from family members and professional sources, and by 
participation in education or training. For those who 
reported drug problems, seeking treatment was a critical 
enabler in the transition to supported housing. Most felt that 
it was important to distance themselves from former peer 
networks and attempted to establish and maintain positive 
and enabling social relationships. Some experienced fi nancial 
diffi culties as well as problems with everyday household 
chores and responsibilities. A number reported feelings of 
loneliness and depression. 
Continued homelessness 
Thirteen of the young people (11 males and two females) 
remained homeless, that is, they continued to access 
emergency hostel accommodation, sleep rough or live in 
other temporary or unstable living situations. Nine were 
aged 19 years or under. Most had left school early, reported 
short-lived attempts at a return to education/training, had 
limited participation in the labour market and weak family 
ties. All had a history of drug misuse and two also reported 
heavy alcohol use; nine reported heroin use. 
Housing instability had a discernible impact on these young 
people’s drug-using behaviour. Moving between temporary 
living places brought them into contact with other drug 
users and also cultivated an acceptance of ‘hard’ drug 
use. Their entry to adult hostels was a point of particular 
vulnerability due, in large part, to the sense of despair many 
experienced at this juncture. Escalating drug consumption 
impacted on their physical and mental health, and 
negatively infl uenced their ability to maintain meaningful 
ties with society. A number had tried to address the matter 
of their drug consumption and several had sought treatment 
at some time. 
Young people’s efforts to address their substance use were 
constantly hampered by the absence of a stable place to live, 
rendering abstinence a constant struggle, as described by 
Eoin (22): 
I’ve been going round in circles for a long time probably 
since back then [time of initial interview] but it’s just 
hard. Like, I was doing well for a while, I’d be doing well 
for a few weeks but then something would happen. I 
get setbacks, you know. Having nowhere to stay is the 
main thing. Staying here, I’m trying to get clean urine 
but as you know it’s, this hostel is for people who’s on 
drugs and I’m sharing a room with a fella and like… I’m 
trying to stay away from everything and he’s doing it in 
me face. It’s just there in me face. It’s just so, it’s just so 
hard. (p. 131)
This research shows that there are pathways out of 
homelessness for young people whose contact with their 
families has remained strong; they receive support in 
accessing treatment for their substance use and in making 
the transition to supported living conditions. The research 
also shows that there are young people who remain trapped 
in homelessness and substance use. They tend to have weak 
ties with family, poor education skills and problems related 
to drug and alcohol use. Despite many making efforts to ‘get 
clean’ their experience of housing instability and exposure to 
adult hostels and the street drug scene can place them at an 
elevated risk of escalating their use of substances and their 
experience of homelessness. 
(Martin Keane)
1. Mayock P, Corr ML and O’Sullivan E (2008) Young 
people’s homeless pathways. Dublin: Homeless Agency.
2. Mayock P and Vekicˇ  K (2006) Understanding youth 
homelessness in Dublin city: key fi ndings from the fi rst 
phase of a longitudinal cohort study. Dublin: Stationery 
Offi ce.
drugnet 
IRELAND
19
An assessment of treatment needs in 
the North Eastern RDTF
The North Eastern Regional Drugs Task Force (NERDTF) 
commissioned a needs assessment study in order to: 
assess the number and profi le of drug-users; ■
assess in-patient and out-patient drug treatment services; ■
explore needs of drug treatment service users and their  ■
families;
identify gaps in service provision; and ■
make recommendations for future service development  ■
and resources required.
The study examined available quantitative data sources 
and also carried out qualitative interviews with a wide 
range of stakeholders, including staff working in addiction 
services, community and voluntary groups, drug users and 
family support groups.1 The NERDTF covers the counties of 
Louth, Meath, Cavan and Monaghan. The main results are 
summarised below.
The study found that drug use in the region had increased in 
recent years. National prevalence data show that almost one 
in four people in the region reported using an illicit drug at 
some point in their life, and one in three in the 15–34-year 
age group. 
The report did not include all data available at the time from 
the National Drug Treatment Reporting System (NDTRS); 
Table 1 presents the complete fi gures for 2001 to 2006, 
showing a 27% increase in the total number of cases over 
the six years.2 This was mainly due to the increase in new 
cases seeking treatment. 
Table 1 Number (%) of cases entering treatment in the former North Eastern Health Board area, 2001 to 2006 
2001 2002 2003 2004 2005 2006
All cases 370 306 387 374 365 471
Previously 
treated cases
 
125 (33.8)
 
99 (32.4)
 
146 (37.7)
 
130 (34.8)
 
125 (34.2)
 
149 (31.6)
New cases 221 (59.7) 186 (60.1) 229 (59.2) 236 (63.1) 224 (61.4) 303 (64.3)
Treatment 
status unknown
 
24   (6.5)
 
21   (6.9)
 
12   (3.1)
 
8   (2.1)
 
16   (4.4)
 
19   (4.0)
According to the NDTRS, the incidence of treated drug use 
in the region for 2001–2006 was to 91.3 per 100,000, an 
increase on the 1998–2002 rate of 50.1 per 100,000.
The main problem drugs identifi ed by the study were 
cocaine, cannabis, alcohol, heroin and prescription drugs. 
The main problem drugs for those entering treatment 
between 2001 and 2006 were cannabis (54%), opiates 
(27%) and cocaine (10%).2
Most of the respondents interviewed felt that drug use was a 
growing problem in the region. Other issues raised included 
the normalisation of cannabis use to the point where it was 
considered equivalent to consuming alcohol. Heroin use 
was associated with social deprivation and rural areas, while 
cocaine was perceived as being used by all social classes, 
with use starting in the late teens. Increased polydrug use 
was also commented on. Increased consumption of alcohol 
by teenagers was reported. 
The report noted that services varied in type, quality and 
availability throughout the region. There was a range of 
outpatient services, but no dedicated inpatient facility for 
drug treatment and detoxifi cation. Underdevelopment 
of the services was suggested as a factor in some of the 
weaknesses in service provision. Other issues raised included 
insuffi cient staff resources in HSE addiction services, limited 
collaboration between statutory and voluntary services, lack 
of a clear focus on polydrug use and lengthy waiting lists. 
Recommendations of the report are summarised below.
Provide services for residential detoxifi cation, out-of- ■
hours treatment, crisis and early intervention, and 
treatment for under-18s.
Provide clear access pathways and accessible information  ■
on the types of service and treatment available.
Move to a continuity of care model, with a case  ■
management approach, and systems to monitor 
progress and outcomes.
Widen the scope of treatment services to cover holistic  ■
care for the client and their family, and improve the 
support services
Develop a set of standards/guidelines to improve the  ■
appropriateness/location of services.
Adjust treatment approaches to respond to polydrug  ■
use including alcohol, and increase harm reduction 
approaches, including needle exchange, health 
education and easy access to low-threshold treatment.
Improve collaboration and communication between  ■
statutory and community services.
(Suzi Lyons)
1. Watters N (2008) Drug treatment: an assessment of needs 
in the North East Region. Navan: North Eastern Regional 
Drugs Task Force.
2. Reynolds S, Fanagan S, Bellerose D and Long J (2008) 
Trends in treated problem drug use in Ireland, 2001 to 
2006. HRB Trends Series 2. Dublin: HRB.
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Study on drug use in Clondalkin 
This timely report1 commissioned by the Clondalkin 
Local Drugs Task Force (CLDTF) was launched on 
7 December 2008 by John Curran TD, Minister of 
State with responsibility for drugs strategy, at Áras 
Chrónáin in Clondalkin. The research team was 
led by Dr Marianne Greene of Merchants Quay 
Ireland with assistance from the Clondalkin Drug 
Users Forum. The CLDTF, entering its third strategic 
review, commissioned the research to ‘defi ne the 
current nature and extent of drug use in Clondalkin 
... in order to inform drug strategy, policy and 
services’ (p. 6).
Both qualitative and quantitative research methods 
were used, including a survey of 150 drug users 
by nine peer research assistants, and focus groups 
with problematic drug users, family members and 
community members. Available relevant statistics 
were also collated, such as Garda crime statistics 
and drug treatment fi gures. 
The report covers a wide range of drug-related 
issues, including information relating to availability, 
prevalence, profi le and patterns of use, drug-related 
health issues and risk behaviours, drug treatment 
and drug-related crime. 
Patterns of drug use and emerging trends
Heroin remains the primary drug of use among 
those attending drug treatment facilities but crack 
cocaine is regarded as an emerging problem drug 
in the Clondalkin area. Polydrug use is common 
and generally involves heroin combined with 
cannabis, cocaine, crack or benzodiazepines. The 
injection of cocaine by injecting heroin users was 
another emerging trend.
Drug dealing and drug related crime 
As drug consumption has become less visible in 
public areas, concerns of the wider community 
have centred upon drug-related crime and the 
normalisation of such crime. A greater amount 
and variety of illegal drugs has become available 
in recent years. Dealing has become more open, 
frequently being conducted in public places, 
and is seen as an attractive and lucrative career 
option for a proportion of young people living in 
Clondalkin. The report highlighted a belief that law 
enforcement focused too much on breaking up 
high-level drug distribution networks rather than 
on disrupting the activities of local dealers. Lenient 
sentencing of drug offenders was also of concern 
to participants.
Drug treatment and harm reduction
On the basis of data from statutory and community 
agencies in the CLDTF area, there appeared to be 
a small decrease in the numbers attending drug 
treatment services in the last three years. Of the 
150 drug users surveyed, nearly two-thirds were 
not accessing drug services at the time of the study, 
while 42% had never accessed drug services other 
than needle exchanges. Over half (59.3%) of the 
81 injecting drug users surveyed reported using 
needle exchanges weekly or monthly. 
Just over one-third of the sample (37.3%) were 
currently on methadone maintenance programmes. 
Typical waiting times for methadone maintenance 
were less than three months (33.3%), and over 
twelve months (29.8%). While there was general 
satisfaction with the methadone programme as 
a stabilising infl uence, some participants were 
frustrated at the lack of a moving-on mechanism 
for those on the programme. The lack of inpatient 
detox facilities was also highlighted in the report. 
(Anne Marie Donovan and Anne Marie Carew)
The report is available from Clondalkin Drugs Task 
Force, telephone (01) 457 9445.
1. Breen M (2008) Nature and extent of drug use in 
Clondalkin. Dublin: Clondalkin Local Drugs Task 
Force.
Directory of courses 2009
The National Documentation Centre on Drug Use 
has published a new edition of the Directory of 
courses and training programmes on drug misuse 
in Ireland. Thirty-six providers sent us information 
about 88 courses for this fourth edition. We would 
like to thank all of those who made contributions.
Most courses refer directly to drugs or addiction, 
though others aim to develop broad skills, such as 
supervision, facilitation and counselling techniques, 
which may be of interest to those working in this 
area. A wide variety of training standards, methods 
and approaches are represented. We do not assess 
the quality of courses listed; we present information 
as supplied by the course co-ordinators on course 
length, assessment, qualifi cations and accreditation. 
Course providers are based in Dublin (66%), Cork, 
Donegal, Kildare, Galway, Leitrim, Mayo, Meath, 
Tipperary and Waterford. Although many cater 
specifi cally for people in their locality, some also 
offer courses on a regional or national basis. 
This year we asked local and regional drugs 
task forces to provide information about their 
educational bursaries. A small number of task forces 
offer fi nancial assistance for those living or working 
in their area to attend specifi ed courses. We provide 
information on their application criteria. 
(Mary Dunne)
Course co-ordinators who wish to revise an existing 
entry or include a new course in the 2010 edition 
of the Directory may request an application form 
from mdunne@hrb.ie
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Kerry Life Education evaluation report
The Kerry Life Education (KLE) project is delivered from a 
fl eet of mobile buses called ‘Life Education’ classrooms that 
visit primary schools in Co Kerry. The project includes a mix 
of health promotion and information and covers diet, self-
esteem, peer dynamics, bullying and alcohol and substance 
use. It has been visiting schools since 2004 and is estimated 
to reach between 5,000 and 7,000 students per year. An 
evaluation of the KLE project has recently been published.1
Methods of evaluation
This was a process evaluation aimed at uncovering the 
perspective of schools, parents and professionals on the 
operation and relevance of the KLE project. A survey 
questionnaire was sent to 68 schools that had participated 
in the project; the response rate was 84%. The principal of 
each school was asked to complete the questionnaire using 
a consensus view between principals, teachers and parent 
representatives. A different survey questionnaire was sent to 
eight key professionals in the fi elds of health promotion and 
education; six responded. In addition, data from the Health 
Behaviour in School-aged Children (HBSC) dataset for 2006 
were analysed and comparisons on a number of variables 
were made between students in KLE schools and students 
from comparison schools in Kerry. 
The perspective of schools
The majority of schools (89%) reported the teaching, 
content and presentation of KLE to be excellent and 
appropriate for children, and 95% wanted the project to 
continue. Ninety per cent reported that KLE was good or 
excellent at supporting individual components of the Social, 
Personal and Health Education (SPHE) programme,2 such as 
learning about the body, making decisions and relating to 
others. Ninety-three per cent reported having a substance 
use policy, with 94% reporting that KLE provided either 
good or excellent support to the development of substance 
use policy. Only 46% reported that parents had received 
input from the KLE project. Ninety-six per cent perceived the 
impact of the project on students to be good or excellent, 
with the same fi gure anticipating the potential impact over 
time to be good or excellent. 
The perspective of key professionals
Three of the six professionals who responded were not 
familiar with the work of KLE prior to being surveyed. 
When they did learn of the project, respondents reported 
mixed views. Public health professionals expressed cautious 
optimism that KLE could provide consistent information on 
substance use, contribute to a holistic approach to health 
promotion and increase the number of health promotion 
sites available to young people. In contrast to the view of 
the majority of schools, the two education professionals 
expressed concern that KLE was short-term and did not 
reinforce the consistent approach taken in SPHE that seeks to 
develop life skills during school-going years. 
Comparison of KLE student data with HBSC data
The evaluators compared data for Fifth and Sixth Class 
students who participated in the KLE project with HBSC 
2006 data from comparison schools in Kerry. Lifetime 
consumption of alcohol was lower among Fifth Class KLE 
students than among students in comparison schools. 
Differences favouring KLE students were noted on a number 
of other variables, including being satisfi ed with life, taking 
more frequent exercise, consuming less soft drinks, snacks 
and chips and being less likely to be involved in incidents 
of bullying. 
When interpreting these favourable results for KLE students it 
is important to note that the sample was small and was 75% 
female. In addition, the differences observed between KLE 
students and students not receiving the intervention cannot 
be attributed solely to the intervention of KLE as any number 
of factors may explain these changes. Further research under 
more controlled conditions is needed before any substantive 
conclusion can be reached. Nonetheless, the KLE project is 
popular among school personnel and parents in Kerry and 
it would be interesting if further research investigated the 
perception of young people regarding the project. 
Evidence shows that short-term interventions delivered on a 
once-off basis are not very useful in making drug education 
effective in young people’s lives. However, when used in 
conjunction with a comprehensive programme such as 
SPHE, they can enhance understanding of the issues being 
addressed and contribute to a perception in the community 
that potential substance use among young people is being 
tackled. Such a perception can undermine the belief among 
young people that substance use is ‘normalised’ and 
tolerated by the community. However, it is important that 
short-term projects are premised on the same theoretical 
basis as the more comprehensive programme that they are 
supporting, otherwise different perceptions can arise among 
stakeholders regarding how interventions operate. Such 
differences are noted in this evaluation – between public 
health professionals and educational experts – and it would 
be helpful to address such differing views if the KLE project is 
to support the delivery of SPHE in Kerry in the future. 
(Martin Keane)
1. Jackson T, Kelly I and Dee A (2008) Kerry Life Education 
project: an evaluation. Cork: Department of Public Health 
HSE South.
2. SPHE stands for Social, Personal and Health Education 
and is the main life-skills programme delivered in primary 
and secondary schools in Ireland. The programme uses 
the Walk Tall component in primary schools to support 
the implementation of substance use education. 
3. McGrath Y, Sumnall H, McVeigh J and Bellis M (2006) 
Drug use prevention among young people: a review of 
reviews. Evidence briefi ng update. London: National 
Institute for Health and Clinical Excellence.
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Trends in alcohol and drug admissions 
to psychiatric facilities
Activities of Irish psychiatric units and hospitals 2007, the 
annual report published by the Mental Health Research Unit 
of the Health Research Board in December 2008, shows 
that the total number of admissions to inpatient care has 
continued to fall.1 
In 2007, 2,699 cases were admitted to psychiatric facilities 
with an alcohol disorder, of whom 808 were treated for 
the fi rst time.1 Figure 1 presents the rates of fi rst admission 
between 1990 and 2007 of cases with a diagnosis of alcohol 
disorder, per 100,000 of the population.1-6 It is notable that 
the rate decreased steadily between 1991 and 2004 and 
more than halved during the reporting period. The rate 
stabilised in 2004 and 2005, but decreased again in 2006 
and 2007. The trend since the early nineties refl ects changes 
in alcohol treatment policy and practice, and the resultant 
increase in community-based and special residential alcohol 
treatment services. Of the 2,743 discharges with an alcohol 
disorder, just under 44% spent less than one week in 
hospital and 17% spent more than one month in hospital. 
Whether or not these admissions were appropriate, and in 
line with the recommendations of the mental health policy, 
A vision for change, could not be discerned from the report 
as the numbers with co-morbid illness were not reported.
In 2006, 724 cases were admitted to psychiatric facilities 
with a drug disorder, of whom 265 were treated for the fi rst 
time.1 The report does not present data on drug use and 
psychiatric co-morbidity, so it is not possible to determine 
whether or not these admissions were appropriate. Figure 2 
presents the rates of fi rst admission between 1990 and 2007 
of cases with a diagnosis of drug disorder, per 100,000 of 
the population.1-6 The rate increased steadily between 1990 
and 1995, with a dip in 1996, and further annual increases 
between 1997 and 2001. The rate was almost three times 
higher in 2001 than it was in 1990. Notable dips in the rate 
occur in the census years 1996 and 2002, and can be partly 
explained by the increased population fi gure used as the 
denominator in calculating the rate for those years. 
The overall increase in the rate of drug-related fi rst 
admissions between 1990 and 2001 refl ects the increase 
in problem drug use in Ireland and its burden on the 
psychiatric services. The overall decrease in the rate since 
2001 possibly refl ects an increase in community-based 
specialised addiction services during this period. The 
increased rate in 2005 may be accounted for by the use of 
the 2002 census fi gure in calculating the rate. The decrease 
to 5.9 in 2006 refl ects the new census fi gure used as 
denominator. The rate increased marginally to 6.3 in 2007. 
Of the 776 discharges with a drug disorder, 51% spent less 
than one week in hospital and just under 13% spent more 
than one month in hospital. 
Figure 1 Rates of psychiatric fi rst admission of cases with a diagnosis of alcohol disorder (using the ICD-10 three 
character categories) per 100,000 of the population in Ireland and reported to the National Psychiatric 
Inpatient Reporting System, 1990 to 2007
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Four cases of botulism among drug 
users 
Alcohol and drug psychiatric admissions (continued)
(Jean Long)
1. Daly A, Walsh D and Moran R (2008) Activities of Irish 
psychiatric units and hospitals 2007. Dublin: Health 
Research Board.
2. Daly A, Walsh D and Moran R (2007) Activities of Irish 
psychiatric units and hospitals 2006. Dublin: Health 
Research Board.
3. Daly A, Walsh D, Ward M and Moran R (2006) Activities 
of Irish psychiatric units and hospitals 2005. Dublin: Health 
Research Board.
4. Daly A, Walsh D, Comish J, Kartalova-O’Doherty Y, 
Moran R and O’Reilly A (2005) Activities of Irish psychiatric 
units and hospitals 2004. Dublin: Health Research Board.
5. Daly A, Walsh D, Moran R and Kartalova-O’Doherty Y 
(2004) Activities of Irish psychiatric services 2003. Dublin: 
Health Research Board.
6. Walsh D and Daly A (2004) Mental illness in Ireland 
1750–2002: refl ections on the rise and fall of institutional 
care. Dublin: Health Research Board.
Figure 2 Rates of psychiatric fi rst admission of cases with a diagnosis of drug disorder (using the ICD-10 three 
character categories) per 100,000 of the population in Ireland and reported to the National Psychiatric 
Inpatient Reporting System, 1990 to 2007
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Botulism is a rare but serious illness caused by botulin toxin. 
The toxin is produced by the bacteria Clostridium botulinum. 
The HPSC was informed of four cases of wound botulism – 
all affecting injecting drug users – in late November 2008. 
Wound botulism is a rare condition. The condition is caused 
by bacteria that are commonly found as spores in soil or 
gravel and can be acquired if a wound is contaminated by 
such material. The bacteria grow in skin abscesses as a result 
of injecting heroin but the bacteria can also reproduce in the 
nasal passages as a result of snorting cocaine. Symptoms of 
botulism usually develop about 12–36 hours after exposure 
to the toxin and normally begin with blurred vision, diffi culty 
swallowing, diffi culty speaking and occasionally breathing 
problems. Diarrhoea and vomiting can also occur and the 
disease can progress to paralysis. In recent years this type of 
botulism has been most commonly reported among chronic 
drug users, in Ireland and elsewhere. Most people (90–95%) 
with botulism will recover with treatment. 
(Jean Long)
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The State Laboratory annual report 2007
‘The State Laboratory provides an analytical and advisory 
service to Government departments and offi ces to support 
their policies, regulatory programmes and strategic 
objectives’.1 The agency’s 2007 annual report focuses on fi ve 
strategic themes: agriculture and food, revenue, the Coroner 
Service and other departments, organisational review, 
modernisation agenda and optional capabilities.
The Human Toxicology section of the laboratory provides 
an analytical service to the Coroner Service and other 
bodies, including the Irish Medicines Board. Between 2000 
and 2007 the laboratory saw a 75% increase in samples 
analysed for the Coroner Service. Despite the increase in 
samples, the laboratory has been able to maintain and even 
improve agreed turn-around times. In 2007 personnel at the 
laboratory attended 2,950 coroners’ inquests to assist the 
coroner in the interpretation of the toxicology report.
Advances have been made in the analytical capacity of the 
laboratory. An automated extraction method for analysing 
cocaine and cannabis samples has been introduced, 
replacing the labour-intensive manual extraction method.  
Work is ongoing on streamlining confi rmatory analysis 
methods which are used for detection and identifi cation 
of substances such as 6-mono acetyl morphine (heroin 
metabolite), methadone, cocaine and dihydrocodeine. 
Other advances include new instrumentation, instrumental 
connectivity and validation methods.
The reported increase in cocaine use in Ireland is mirrored 
in the rise in the number of post-mortem samples sent to 
the laboratory for analysis for cocaine. The results of tests of 
human biological samples support the view that much of the 
cocaine used in Ireland is adulterated with other substances, 
most frequently lidocaine (brand name Lignocaine), 
diltiazem (a benzodiazepine) and phenacetin (a type of 
analgesic). The toxic effect of cocaine is increased when it is 
mixed with such substances, particularly lidocaine.
The goal of the State Laboratory in relation to the Coroner 
Service and other departments is to provide a timely high-
quality service and to meet present and future demands 
in areas such as forensic toxicology, health and safety 
compliance and environment and heritage protection.
(Simone Walsh)
The State Laboratory website is at www.statelab.ie
1. The State Laboratory (2008) Annual report 2007. Kildare: 
The State Laboratory.
EU Drugs Action Plan evaluated
The EU places great store on evaluation. The European 
Commission has published guidelines on evaluating both 
programmes and policies,1 and the European Monitoring 
Centre for Drugs and Drug Addiction (EMCDDA) has made a 
special study of the evaluation of national drugs strategies.2 
In December 2008 the fi nal evaluation of the EU Drugs 
Action Plan 2005–2008 was published.3 This report provides 
an interesting case study of how to conduct an evaluation. 
Designing the evaluative framework
The objectives of the evaluation of the EU Drugs Action 
Plan were defi ned by reference to the plan’s underlying 
purpose, which is to act as a co-ordination instrument. 
Three evaluative objectives were identifi ed: (1) to establish 
the extent to which the outputs specifi ed in the plan were 
delivered, (2) to gauge the outcomes, i.e. the impact of the 
actions on the drugs situation, and (3) to assess the 
process, i.e. the value added of the Action Plan as a policy 
instrument per se. Each objective was supported by two 
questions which explored different aspects of the objective. 
Probing the nature of the relationship between actions and 
their impacts, these questions resulted in comprehensive 
answers (see table). 
Summary of the evaluative framework applied to, and key fi ndings of the evaluation of, the EU Drugs Action Plan 
2005–2008 
Objectives Questions Answers
To establish to what 
extent the objectives 
and actions of the 
Action Plan have 
been achieved.
To what extent have the 
operational objectives and actions 
in the current EU Action Plan on 
Drugs been implemented and 
what are the main outputs?
The EU Drugs Action Plan is mainly a co-ordination instrument, 
pulling together the main strands of drug policy. It is a non-
binding co-ordination document for member states, which are 
autonomous in implementing its aims and objectives. Have the 
specifi c priorities in the Strategy and the operational objectives 
in the Action Plan been adopted by member states?
Have the specifi c priorities in 
the Strategy and the operational 
objectives in the Action Plan been 
adopted by member states?
The EU Drugs Strategy and Action Plan are suitably refl ected 
in national policies. The evaluation shows that member states 
have translated the objectives of the Action Plan into national 
policy, and/or that these objectives were already refl ected in 
existing documents. (1) Member states report that the Action 
Plan refl ects the main policy fi elds at national level. Some 
national priorities are not covered, mostly owing to differences 
in the drug situations in member states. (2) The evaluation 
shows that the Action Plan supports a process of convergence 
between member states’ drug policies and helps to achieve 
policy consistency between countries.
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EU Drugs Action Plan (continued)
Objectives Questions Answers
To understand the 
relationship between 
the Action Plan and 
the actual drug 
situation.
What are the overall changes 
in the drug situation in recent 
years?
Although there has not been a signifi cant reduction in the 
prevalence of drug use, the use of the most prevalent drugs 
seems to have stabilised and/or fallen slightly. The use of 
cocaine is showing an upward trend in some member states.
To what extent can these changes 
be linked to the implementation 
of the EU Action Plan on Drugs?
The stabilisation in prevalence levels of most illicit drugs 
except for cocaine cannot be linked to specifi c interventions 
implemented through the Action Plan.
To estimate the 
added value that the 
Action Plan offered to 
drug policy in the EU 
as a whole.
What is the overall added value 
of the EU Drugs Action Plan 
2005–2008?
Member states consider that the Action Plan has added value 
at both EU level and for national policy, where the Action Plan 
functions as a guiding document.
What key conclusions and 
lessons can be drawn from this 
evaluation for the next plan 
covering the years 2009 – 2012?
See the article on the EU Drugs Action Plan 2009–2012 below.
Obtaining the necessary information
To obtain the information needed to answer the evaluative 
questions, fi ve sources of information were used. Objective 
information on trends in the drug situation in Europe 
and the responses to it was collected, and the views of 
member states regarding the Action Plan were surveyed. 
Various analyses were undertaken, including a refl ection 
on the structure, logic and clarity of the EU Drugs Strategy 
(2005–2012) and the related EU Drugs Action Plan 
(2005–2008), a review of the implementation of the actions 
and achievement of the objectives, and an assessment of 
intra-institutional co-ordination and co-operation in the 
implementation of the Action Plan. 
Ensuring stakeholder buy-in
To ensure a comprehensive evaluation, the Commission 
set up a Steering Group comprising representatives of the 
main stakeholder groups – the member states holding the 
EU presidency between mid-2006 and the end of 2008, the 
European Parliament, Europol, the EMCDDA, and Eurostat. 
This group advised on the choice of evaluation methodology 
and the interpretation of the evaluation outcomes. The 
Commission also sought input from the Civil Society Forum 
on Drugs. In its introductory section, the succeeding EU 
Drugs Action Plan 209–2012 commented that the evaluation 
of the 2005–2008 Action Plan was ‘the most extensive 
assessment of EU drug policy to date and shows that the 
objectives of the present Plan have been partly achieved’.
(Brigid Pike)
1. Commission of the European Communities (2004) 
Evaluating EU activities: a practical guide for the 
Commission services. Luxembourg: Offi ce for Offi cial 
Publications of the European Communities.
2. EMCDDA (2004) Evaluation of ‘national drugs strategies’ 
in Europe. Selected issue. In Annual report 2004: the state 
of the drugs problem in the European Union and Norway. 
Luxembourg: Offi ce for Offi cial Publications of the 
European Communities.
3. Commission of the European Communities (2008) 
Report of the fi nal evaluation of the EU Drugs Action Plan 
(2005–2008). Commission staff working document. 
Accompanying document to the Communication from 
the Commission to the Council and the European 
Parliament on an EU Drugs Action Plan 2009–2012. 
Brussels: European Commission, DG Justice, Freedom 
and Security.{COM (2008) 567}; {SEC (2008) 2455}; 
{SEC (2008) 2454}.
EU sets priorities for drug policy 
2009–2012 
On 8 December 2008 the European Council endorsed the 
EU drugs action plan for 2009–2012.1 While using the same 
fi ve activity areas as the previous action plan (co-ordination, 
demand reduction, supply reduction, international co-
operation, and research, information and evaluation), the 
new plan reduces the number of objectives from 45 to 24 
and increases the number of actions from 61 to 72.2 As 
a result, the EU’s drug policy priorities for the next four 
years are more clearly defi ned than previously. Some key 
innovations with implications for Ireland’s drugs policy are 
noted below.
Create a European Alliance on Drugs
Having established the European Civil Society Forum on 
Drugs in 2006,3 the European Commission will now form 
a European Alliance on Drugs. This alliance will allow 
civil society organisations from across the EU, including 
schools, commercial enterprises, public bodies and non-
governmental organisations, to participate in a common 
framework designed ‘to create public commitment about 
and to take action on drug problems in society’. The action 
plan also calls on member states to involve civil society at 
all appropriate levels of drugs policy, ‘in accordance with 
national practices’. 
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EU priorities for drug policy (continued)
Seek an EU consensus on minimum standards for 
demand reduction activities 
The action plan lists 10 actions to be implemented 
by member states, covering all aspects of demand 
reduction – prevention, treatment, rehabilitation 
and reintegration. Harm reduction measures are 
included to reduce both the spread of blood-borne 
infectious diseases and the number of drug-related 
deaths in the general population, and health-
related harms associated with drug use in prison. 
Member states are to pay particular attention to 
meeting the needs of vulnerable and minority 
groups and to preventing polydrug use (combined 
use of illicit and licit substances, including alcohol, 
volatile substances and tobacco).
At EU level there will be a drive to enhance the 
quality and effectiveness of these activities. Member 
states will be requested to survey the availability 
and effectiveness of prevention, treatment, harm 
reduction and rehabilitation services, in responding 
to specifi c needs, using a methodological 
framework to be developed by the European 
Commission. The Commission will then seek to 
develop an EU consensus on minimum standards 
and benchmarks.
Achieve a measurable improvement in 
effectiveness of supply reduction activities 
Nineteen actions focus on enhancing co-operation 
between law enforcement agencies and the 
judiciary in the member states in tackling the 
production and traffi cking of drugs, including the 
manufacture and supply of synthetic drugs and the 
diversion of traffi cking of drug precursors. 
The need to improve responsiveness to emerging 
threats, such as new drugs or new traffi cking 
routes, is emphasised. Regional security platforms 
are to be set up where and when needed. MAOC-N 
(Maritime Analysis and Operations Centre – 
Narcotics), of which Ireland, which controls some 
16% of the EU’s territorial waters, was a founding 
member in 2007, is cited as an example of this 
type of mechanism. Moreover, member states and 
regions with high exposure to ‘particular drug 
production/traffi cking phenomena’ are to be the 
focus of co-ordinated and joint efforts at EU level.
Promote the European balanced approach to the 
drugs problem worldwide
The action plan includes four actions calling for 
better co-ordination and continuity between EU 
and member state policy positions in international 
forums on aspects of drug policy. An agreed EU 
position, refl ecting the fundamental principles of 
EU drug policy, is to be presented at the high-
level segment of the 52nd Session of the UN’s 
Commission on Narcotic Drugs (CND), to be held 
in Vienna in March 2009. This Session will see the 
fi nal evaluation of, and agreement on the follow-
up to, UNGASS 1998; the EU is seeking to have 
the EU position included in the new UN Political 
Declaration on illicit drugs.4 
Improve understanding of the drugs problem
The action plan asserts that improved 
understanding will lead to an expanded knowledge 
base both for public policy and for citizens’ 
awareness of the social and health implications of 
illicit drug use. The European Commission is to 
take the lead in (1) establishing research priorities 
and identifying mechanisms to generate new 
knowledge and to put a proposal on this matter to 
the European Council; (2) developing indicators/
measures of drug-related crime, illegal cultivation, 
drug markets and supply reduction interventions, 
and identifying means of collecting the relevant 
data; and (3) devising analytical instruments 
to better assess the effectiveness and impact of 
drug policy, e.g. model evaluation tools, policy 
effectiveness indices, and public expenditure 
analysis. 
Member states are charged with evaluating and 
fi ne-tuning national drug policies on a regular basis, 
and with providing the necessary resources to meet 
the reporting obligations and quality standards 
established by the EMCDDA for the provision 
of national data required for monitoring and 
evaluation purposes. 
(Brigid Pike)
1. European Council (8 December 2008) EU drugs 
action plan 2009–2012. Offi cial Journal of the 
European Union (2008/C 326/09), 20 December 
2008.
2. For information on the previous action plan, see 
B Pike (2005) EU action plan on drugs 2005–
2008. Drugnet Ireland, (14): 3.
3. For information on the work of the Forum, see 
B Pike (2008) EU civil society forum discusses 
new EU action plan on drugs. Drugnet Ireland, 
(27): 23.
4. For background information on UNGASS 1998, 
see B Pike (2008) UN assesses progress in 
tackling world drug problem. Drugnet Ireland, 
(26): 25–26. 
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Irish Prison Service annual report 2007 
The Irish Prison Service (IPS) annual report for 2007 
details developments in drug supply reduction measures, 
rehabilitation and treatment services to prisoners 
during 2007.1 
Sentenced committals for drug offences increased by 34%, 
from 395 (6.5% of total offences) in 2006 to 530 (8.2% 
of total offences) in 2007. These fi gures do not include 
people who were imprisoned for drug-related offences, 
such as economic acquisitive crimes committed to support 
a drug habit. Given the clear link between drug use and 
economically motivated crime, it can be assumed that 
many of those imprisoned for property offences were 
problematic drug users. Of the 530 offenders sentenced for 
drug offences, 267 received prison sentences of up to one 
year, 241 received sentences from one to 10 years and 22 
received sentences of more than 10 years. 
Section 36 of the Prisons Act 2007, which came into 
operation on 1 May 2007, makes it an offence for prisoners 
to have unauthorised possession or use of mobile phones. 
Phones are viewed by the prison authorities and the Garda 
Síochána as contributing to illegal activity outside the prison. 
It is reported that by the end of 2007 more than 2,124 
mobile phones had been seized in Irish prisons. Other supply 
reduction measures reported included:
New prison visiting arrangements whereby only • 
identifi ed and known persons are allowed to 
visit prisoners, ‘reducing the likelihood of visitors 
attempting to pass drugs, and of prisoners being 
coerced into receiving visits from persons not known 
to them to facilitate the passing of drugs’ (p. 25);
Enhanced perimeter security involving improved • 
netting and closer co-operation with the Garda 
Síochána to arrest and prosecute persons attempting 
to convey drugs into prisons;
Improved technology for searching cells and prison • 
property;
The introduction of drug detection dogs;• 
The establishment of an Operational Support Group • 
dedicated to developing expertise in searching and 
intelligence gathering.
Measures advanced during 2007 to enhance drug 
rehabilitation included:
The awarding of a contract for the provision of • 
addiction counsellor services;
The allocation of additional nurse offi cers and prison • 
offi cers to dedicated drug treatment teams;
The provision of funding to community groups • 
to provide addiction counselling and support to 
prisoners while in prison and on their release in the 
community.
The IPS also reports that ‘Considerable work was undertaken 
during the year in consultation with practitioners at local 
prison level to draft a Drug Treatment Clinical Policy 
document to provide guidance to practitioners regarding 
various clinical issues that may arise in treating addiction in a 
prison context’ (p. 26).
As shown in Table 1, nine prisons provided methadone 
treatment to 1,840 prisoners in 2007, of which 185 were 
receiving methadone for the fi rst time. It is noteworthy that 
methadone treatment was not provided in two large prisons, 
namely Cork and Castlerea.
Table 1 Numbers of individuals receiving methadone treatment* in Irish prisons in 2007
Prison Total patients 
during 2007
New patients 
in 2007
Patients at 
31 December 2007
Cloverhill Prison 710 124 176
Dochas Centre 225 26 38
Limerick Prison 10 0 3
Midlands Prison 90 8 30
Mountjoy Main Prison 474 9 112
Mountjoy Prison Medical Unit 120 8 53
Portlaoise Prison 3 1 1
St Patrick’s Institution 15 0 6
Wheatfi eld Prison 193 9 90
Total 1840 185 509
*Methadone treatment in this context is either substitution or detoxifi cation. 
Source: IPS (2008)
(Johnny Connolly)
1. Irish Prison Service (2008) Annual report 2007. Longford: 
Irish Prison Service.
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From Drugnet Europe
Towards the better treatment of addiction
Cited from article by Roland Simon in Drugnet Europe No. 65, 
January–March 2009
Ongoing research can make a valuable contribution to the 
effective treatment of drug addiction. This is according to 
high-ranking scientists attending the European Conference 
of Scientifi c Experts, held in Paris from 9–10 December. 
Organised under the French Presidency of the EU by the 
Interdepartmental mission for the fi ght against drugs and 
drug addiction (MILDT), the event was entitled ‘How can 
we better treat drug addiction? New scientifi c and clinical 
challenges for Europe’.
… A session dedicated to neurobiology showed how better 
insight into the mechanisms underlying addiction could 
improve interventions. Approaches for treating cocaine 
and crack addictions were also explored, such as the use 
of central nervous system (CNS) stimulants as a cocaine 
substitution. Also presented were the fi rst results of a 
European adaptation of a US family-based behavioural 
therapy programme for problem cannabis users, as well as 
lessons to be learnt from cases of self-healing. 
The researchers expressed concern over lack of sustainability 
(e.g. short-term funding) and problems in putting theory 
into practice. Possible remedies were discussed … [including] 
longer-term planning and funding; an adequate slot for 
drug-related research in future EU research framework 
programmes; better integration of national and EU funding 
for addiction research; and the creation of research 
clusters for better collaboration and concentration on 
specifi c themes.
For a summary and full report, see http://mildt.systalium.
org/article6022.html
Drug use, a growing challenge for EU road safety
Cited from article by Dominique Lopez and Brendan Hughes in 
Drugnet Europe No. 65, January–March 2009
Alcohol remains the number one substance endangering 
lives on European roads, but more drivers are now found 
to be using illicit drugs and psychoactive medicines … . 
The [EMCDDA] report, Drug use, impaired driving and traffi c 
accidents, a review of the latest research in this fi eld, explores 
the potential impact on road safety.1 …
The report is dedicated to the effects and risks associated 
with the use of individual substances or with multiple drug 
use. … “Preventing driving under the infl uence of drugs is 
targeted by the current EU drugs strategy 2005–12 and its 
action plans”, said EMCDDA Director Wolfgang Götz, “and 
policymakers are increasingly called upon to respond to the 
problems of road fatalities linked to licit and illicit substances.” 
Research covered in the report is broadly split into two 
types: epidemiological and experimental. Epidemiological 
studies examine the prevalence of drugs in driving 
populations, and are conducted through a range of surveys 
(e.g. roadside, hospitals). Experimental studies, where a 
drug is administered to volunteers in measured doses, … 
show that most illicit drugs can affect some aspect of driving 
performance and increase the risk of being involved in a 
traffi c accident. And chronic (long-term) use of any illicit 
drug can decrease driving performance, even when the 
subject is no longer intoxicated.
1. www.emcdda.europa.eu/publications/insights/driving 
New thematic paper on indicated prevention
Cited from Drugnet Europe No. 65, January–March 2009
The EMCDDA published its latest online thematic paper in 
February entitled: Preventing later substance use disorders 
in at-risk children and adolescents: a review of the theory 
and evidence base of indicated prevention. The study adds 
to the current knowledge and understanding of risk factors 
in the development of later drug problems, focusing on the 
mental health and behavioural problems that develop during 
childhood. The study also identifi es models of best practice 
for prevention activities targeting vulnerable children in 
European countries. 
Indicated prevention is a relatively new branch of drug 
prevention and describes a preventive approach targeting 
individuals at high risk of developing substance abuse or 
dependence later in life. Drawing on the current scientifi c 
literature, the study describes the results of research into 
psychosocial and individual risk and protective factors. The 
neurobiology of drug use and how childhood psychiatric 
disorders can predispose to addiction are described in detail. 
One chapter of the report is devoted to the ethical issues 
raised by indicated prevention. The report also contains a 
wealth of practical information. This includes guidelines for 
the assessment and treatment of specifi c psychiatric risk 
conditions for adolescent substance abuse, and detailed 
information on the indicated prevention programmes that 
have been identifi ed in the study.
Downloadable from www.emcdda.europa.eu/publications/
thematic-papers
Drugnet Europe is the quarterly newsletter of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). 
Drugs in focus is a series of policy briefi ngs published by the EMCDDA. Both publications are available at 
www.emcdda.europa.eu 
If you would like a hard copy of the current or future issues of either publication, please contact: 
Alcohol and Drug Research Unit, Health Research Board, Knockmaun House, 42–47 Lower Mount Street, Dublin 2. 
Tel: 01 2345 127; Email: adru@hrb.ie
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In brief
On 30 September 2008 a nationwide Dial-to-Stop Drug 
Dealing initiative was launched by John Curran TD, Minister 
of State with responsibility for drugs strategy. This non-Garda, 
confi dential Freefone service is being phased in across local 
and regional drugs task force areas between October 2008 and 
May 2009. An overall evaluation of the project is due to be 
available in summer 2009. Freefone 1800 220 220
On 5 November 2008 the closure of the Harristown 
Residential Alcohol and Drug Treatment Centre, which is 
funded by the Probation Service and located in the grounds 
of Castlerea Prison, County Roscommon, was debated in Dáil 
Éireann. Closure had been recommended by the authors of a 
Review of adult probation residential centres, commissioned 
by the Probation Service. The evaluators commented: ‘There 
is demand for an addiction treatment service for offenders and 
the evaluators recommend establishing a new service with a 
component to address offending behaviour linked to the most 
suitable addiction treatment model in the Harristown facility 
with a new strategic partner.’ 
www.probation.ie / www.oireachtas.ie 
From 17 to 18 November 2008 the European Crime 
Prevention Network (EUCPN) held its annual conference 
in Paris. This year’s theme was crime prevention in urban 
public spaces, focusing on three main areas: planning of 
public spaces, video protection and daily actions of public 
space management. The aim of the network is to facilitate 
the exchange of ideas on crime prevention issues between EU 
member states, including policies followed by member states, 
and initiatives taken by local and regional authorities and 
associations. www.eucpn.eu 
On 25 November 2008 substitution treatment was the 
subject of a Parliamentary Question in Dáil Éireann. Reporting 
on recent fi gures relating to the provision of methadone 
treatment in Ireland, Minister for Health Mary Harney TD 
stated that a feasibility study on the prescribing and dispensing 
of Subutex and Suboxone in certain specialist addiction 
clinics and in a selected number of community settings would 
commence shortly. www.oireachtas.ie 
On 26 November 2009 a research report, Young people on 
remand, was launched by Barry Andrews TD, Minister of State 
for Children and Youth Affairs. The study found that the most 
common outcome (80%) of remand hearings at the Dublin 
Children Court was a decision to remand a young person on 
bail. However, over one-third of the professionals consulted 
noted that young people ‘rarely’ or ‘never’ understood what 
it meant to be on bail. The study identifi ed a core group of 
young people who, according to the authors, ‘are deeply 
entrenched in the youth justice system and are likely to benefi t 
from bail support and alternatives to remand programmes in 
order to reduce their risk of future detention.’ www.omc.ie 
On 26 November 2008 the Irish Defence Forces Compulsory 
Random Drug Testing (CRDT) programme was the subject 
of a Parliamentary Question in Dáil Éireann. Minister for 
Defence Willie O’Dea TD reported that, since the programme’s 
introduction in October 2002, 8,422 tests had been 
conducted, with 34 tests yielding a positive result (0.4%). 
www.oireachtas.ie 
On 18 December 2008 the Spent Convictions Bill 2007 was 
introduced in Dáil Éireann for its second reading. The Bill is 
intended to apply where a prison sentence not exceeding six 
months or a fi ne or penalty have been imposed, and then 
only after a certain number of years have elapsed without a 
further conviction. The purpose of the Bill is to help rehabilitate 
convicted persons through facilitating their reintegration 
into the workforce and allowing them to build new careers. 
Following a debate, the Bill was referred to the Select 
Committee on Justice, Equality, Defence and Women’s Rights. 
www.oireachtas.ie 
On 6 January 2009 the Czech Presidency of the EU released 
its work programme for January–June 2009. It made the 
following statement with regard to combating drugs: ‘ … the 
attention of the Presidency will focus on the implementation of 
an EU Drugs Action Plan for 2009–2012; issues concerning the 
production and use of amphetamines; and the coordination 
of the joint position of the EU for the regular session of the UN 
Commission on Narcotic Drugs [to be held in Vienna between 
11 and 20 March 2009].’ www.eu2009.cz 
On 12 January 2009 a campaign of action with regard to 
the National Drugs Strategy was agreed by over 150 activists 
and community representatives meeting in Dublin. Six key 
demands were identifi ed:
1. A Minister for the Drugs Strategy at the cabinet table 
(Super Junior) 2. Immediate mandate to drugs task forces 
to develop new plans to meet local needs, and statutory 
agencies to be instructed to engage 3. Guarantee YPFSF to 
remain targeted on drugs prevention 4. Resources to be made 
available to implement the Rehabilitation Strategy 5. Mandate 
and resources to task forces to begin developing response to 
alcohol 6. Community policing fora to be established without 
delays www.citywide.ie 
On 16 January 2009 the European Commission published 
the 818 submissions it received in its public consultation on 
future priorities, including illicit drugs, in the area of freedom, 
security and justice for 2010–2014, together with the results 
of a Eurobarometer survey on awareness of key policy issues 
in the same area. The Commission will use these inputs to 
inform its proposal for the next multi-annual programme in 
the area of freedom, security and justice to follow the Hague 
Programme in 2010. The Commission has posted all the 
public submissions and the results of the opinion survey on its 
website. http://ec.europa.eu/justice_home/news/consulting_
public/news_consulting_0001_en.htm and http://ec.europa.eu/
public_opinion/fl ash/fl _252_en.pdf 
On 19 January 2009 the Children’s Rights Alliance, a 
coalition of 80 NGOs that work to secure the rights and 
needs of children in Ireland, published the fi rst in what is 
expected to be an annual ‘report card’, Is the government 
keeping its promises to children? The report card analyses 
key commitments in the areas of education, health, material 
wellbeing, and safeguarding childhood. With regard to the 
protection of children from the negative consequences of 
alcohol use, it states that ‘a piecemeal approach is being taken, 
while the real problem is being ignored’. The Alliance calls for 
the implementation of the recommendations in the Strategic 
Task Force on Alcohol in relation to ‘protecting children’ and 
the introduction of a legislative ban to protect children from 
unnecessary exposure to alcohol marketing. 
www.childrensrights.ie 
Meeting on 26–27 January 2009 the Pompidou Group’s 
Research Platform1 agreed to investigate the theoretical 
underpinnings for an integrated illicit drug and alcohol 
policy, and to publish later this year a synthesis of recent 
developments in psychological, biomedical and sociological 
research relevant to the drug problem. 
www.coe.int/T/dg3/pompidou 
(Compiled by Brigid Pike)
1. The Pompidou Group is a multidisciplinary co-operation 
forum to prevent drug abuse and illicit traffi cking in drugs, 
set up in 1971 and incorporated into the Council of 
Europe in 1980. It comprises six platforms – prevention, 
treatment, criminal justice, research, ethics and airports. 
Ireland is one of 35 member states that participate in the 
Pompidou Group.
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Recent publications
Journal articles
The following abstracts are cited from recently published 
articles relating to the drug situation in Ireland.
The role of alcohol in deaths presenting to the Coroner’s 
Service in Cork city and county
Bellis M, Bolster MA and Doyle CT 
Irish Medical Journal 2009; 101(1): 13–15
A retrospective study was conducted in order to determine 
the prevalence and concentration of alcohol in post-mortem 
blood samples sent for toxicological analysis in Cork city and 
county in 2003 and 2004.
Post-mortem reports of these deaths were reviewed for the 
presence or absence of alcohol at the time of autopsy, blood 
alcohol concentration (BAC) at time of death, age and sex 
of the decedents. Of samples sent for blood alcohol analysis 
(BAA), 38.4% were positive for alcohol.
Signifi cant differences were found between the proportions 
of alcohol-positive cases by cause of death. Alcohol-positive 
cases were signifi cantly younger (44.3 ± 17.8 years) than 
alcohol-negative cases (51.9 ± 19.4years) and 52% of drivers 
were positive for alcohol at the time of death.
Awareness of the harmful and potentially fatal effects of 
alcohol should continue to be raised within the community, 
so as to prevent future fatalities.
Drug and solvent misuse in national school children in 
mid-west Ireland
Houghton F, Cowley H, Meehan F and Kelleher K 
Irish Journal of Psychological Medicine 2008; 25(4): 157–160
This study provided a baseline assessment of the level 
of drug and solvent misuse by national school children 
in the mid-west region of Ireland. Although the results 
are encouraging in relation to cannabis and may dispel 
anecdotal concerns, the level of experimentation with 
glue/solvents, particularly among males, is an issue given 
its potential lethality. The authors qualifi ed their results by 
noting that the survey focused only on children attending 
national school on the survey date. It is probable that 
children from more chaotic backgrounds where drug misuse 
may be an issue were under-represented in this study.
The extent and nature of family alcohol and drug use: 
fi ndings from the Belfast youth development study
Percy A, Thornton M and McCrystal P 
Child Abuse Review 2008; 17(6): 371–386
Using data from an ongoing longitudinal study of adolescent 
drug use, this study examines the proportion of teenagers 
living with parents who are problem alcohol or drug users. 
Around 2% of parents report high levels of problem drinking 
and 1% report problem drug use. 
If a broader defi nition of hazardous drinking is used, the 
proportion of teenagers exposed increases to over 15%. 
When substance use is examined at a family level (taking 
account of alcohol and drug use among dependent children 
in addition to that of parents), the proportion of families 
experiencing some form of substance use is considerable. 
These fi ndings add further support to the call for increased 
recognition of the needs of dependent children within 
adult treatment services when working with parents. 
Likewise, the reduction of harm to children as a result of 
parental substance use should be an increasingly important 
priority for family support services. This is likely to be 
achieved through the closer integration of addiction and 
family services. 
Methadone and HCV treatment
McCormick PA, Keavney M, O’Toole S and Moloney J 
Irish Medical Journal 2008; 101(10): 316–317
Relatively few patients infected with the hepatitis C virus 
through intravenous drug abuse receive effective antiviral 
therapy. The aim of this study was to determine if supervised 
treatment in a drug treatment centre could improve 
compliance with antiviral therapy. A pilot study of supervised 
anti-viral treatment in a community non-residential drug 
treatment facility was conducted. Thirteen patients infected 
with hepatitis C virus genotype 2 or 3 were identifi ed in a 
drug treatment clinic. Six patients agreed to treatment. Full 
treatment course was administered in all six, with sustained 
viral response in 5/6. This study demonstrates that effective 
treatment penetration can be improved for this patient 
group by shared care with drug treatment services, without 
the need for signifi cant increases in resources.
A qualitative study of Irish teachers’ perspective of 
student substance use
Van Hout MC and Connor S 
Journal of Alcohol & Drug Education 2008; 52(1): 80–91
This research aimed to provide an anecdotal perception of 
student substance use according to the teachers’ personal 
experience in the Irish secondary level educational setting.
Interviews were conducted with 95 teachers at 10 randomly 
selected schools in county Carlow. The school type included 
vocational, secondary in disadvantaged area, secondary 
in non-disadvantaged area, youth training centre, private 
school and both mixed/single sex schools. 
The interview contained questions regarding experience 
of substance abuse within the school setting, knowledge 
and recognition of substance use in students, awareness of 
school drug and alcohol policy, attitude toward substance 
misuse and drug education, awareness of drug availability 
in the area and knowledge of drug-related services in their 
area. A thematic analysis procedure was used to generate 
lists of key ideas, words, phrases, and verbatim quotes. These 
were then formulated into categories and topics. 
The authors found that teachers perceived that drug 
education in schools was ’haphazard, dissimilar and rather 
hit and miss‘, with not every class receiving it, others 
receiving it as part of religious education and Social Personal 
and Health Education and the remainder being visited by 
the local drug education offi cer, a former addict or a juvenile 
liaison offi cer. Teachers highlighted the need for information 
and teacher-specifi c training in order to recognise the 
warning signs of adolescent problematic substance use, 
as many felt this social problem was impacting on their 
classroom and the academic performance of some students. 
Some teachers also reported not feeling comfortable with 
the delivery of drug educational material within their class 
time due to lack of appropriate training and lack of available 
time in their curriculum, in addition to feeling that this was 
not compatible with their role as educators.
drugnet 
IRELAND
31
Upcoming events
(Compiled by Louise Farragher – lfarragher@hrb.ie)
April
20–23 April 2009
Harm Reduction 2009: IHRA 20th International Conference
Venue: Imperial Queen’s Park Hotel, Bangkok, Thailand 
Organised by / Contact: The International Harm Reduction 
Association and the Conference Consortium 
Tel: +44 (0) 20 7554 8533 
E-mail: info@ihraconferences.com 
www.ihra.net/Thailand/Home
Information: IHRA’s harm reduction conferences have been 
held around the world each year since 1990. The theme 
for the 2009 event will be ‘Harm Reduction and Human 
Rights’. Over four days, this conference will be the main 
meeting point for all those interested in harm reduction – 
with over 60 sessions, 250 speakers and 300 posters as well 
as a fi lm festival, workshops, a conference party, exhibitions 
and networking events. It will be an invaluable platform for 
advocacy, debate, and discussion around harm reduction – 
the key forum for the dissemination of harm reduction ideas 
and practice.
23–26 April 2009
Asking the right questions in the right way: re-evaluating 
alcohol research & treatment for the 21st century
Venue: Stranmillis College, Belfast, Northern Ireland 
Organised by / Contact: New Directions in the Study of 
Alcohol Group 
Tel: +44 (0)141 548 4507 
Email: carol.driver@actiononaddiction.org.uk 
www.newdirections.org.uk 
Information: This year’s conference incorporates a research 
symposium from the Alcohol Education Research Council. 
Following international studies that found no apparent 
differences between treatments, NDSAG takes up the issue 
of ‘asking the right questions in the right way’ challenging 
traditional research. We will examine the relationship 
between research design and real world change processes. 
It is time to take a realistic, long term view on treatment 
effectiveness and consider service users’ views.
The conference is designed for practitioners, managers, 
researchers, commissioners and anyone else interested in the 
alcohol fi eld. It will feature the usual mix of erudition, hard 
work, robust debate and informality: a proven formula that 
promotes high quality learning and networking. Confi rmed 
presenters include: Jim Orford (Birmingham); Lawrence 
Kirkpatrick (Belfast); Shane Butler (Dublin); and Gillian 
Tober (Leeds).
May
5–8 May 2009
31st SALIS Conference. Setting Sail: Best Practices for the 
Next Decade
Venue: Halifax, Nova Scotia, Canada 
Organised by / Contact: Substance Abuse Librarians and 
Information Specialists / Ruth Hart or Sheila LaCroix 
Email: ruth.hart@gov.ns.ca / Sheila_Lacroix@camh.net 
http://salis.org/conference/call_for_abstracts.html 
Information: The SALIS conference committee invites 
presentations that focus on identifying or creating best 
practices in librarianship, knowledge or information 
management relating to all aspects of addictive behaviours, 
and especially encourages presentations on the themes of:
Exploring and defi ning the future role of librarians,  ■
knowledge or information managers;
How we can use technology, partnerships or other best  ■
practices to build the relationships and to develop the 
skills to get us there; and
Presentations at a special half-day session, “Web 2.0:  ■
SALIS, Let’s Get Social”. Share and showcase, in a 15 
minute presentation, your experiences with Web 2.0.
June
1–5 June 2009
35th Annual Alcohol Epidemiology Symposium of the Kettil 
Bruun Society
Venue: City Campus, University of Copenhagen 
Organised by / Contact: Kim Bloomfi eld, University of 
Southern Denmark, and Esbjerg Jakob Demant, Center for 
Drug and Alcohol Research 
Email: Kbs2009@crf.au.dk 
www.kbs2009.dk 
Information: The primary purpose of the conference is 
to provide a forum where researchers involved in studies 
on alcohol can exchange ideas about their ongoing 
research. The scope of the symposium includes studies 
of determinants and consequences of drinking, drinking 
practices and attitudes, and the social and institutional 
responses to drinking-related harms. Empirical research, 
theoretical papers and reviews of the literature are welcome. 
Epidemiology is broadly construed and includes research 
in a variety of disciplines, such as psychology, sociology, 
criminology, economics, history and other disciplines.
The Symposium focuses on discussion of papers that are 
pre-circulated electronically at this website. Papers are 
presented in 10-minute segments, followed by a discussant’s 
comments and general audience participation. Any person 
who submits a paper may be asked to be a discussant or 
chair of a session.
2–5 June 2009
12th European Federation of Therapeutic Communities 
Conference: Eyes on the future
Venue: World Forum Convention Center, The Hague 
Organised by / Contact: Brijder Verslavingszorg and 
Verslavingszorg Noord Nederland (VNN) (Dutch institutions 
for addiction care) 
Chair of Local Organising Committee: Mark de Haan 
www.eftc-bepartofthesolution.eu 
Information: The European Federation of Therapeutic 
Communities invites abstracts for this conference on 
rehabilitation and drug policy. Further details are on the 
EFTC website. The main conference themes are:
Effectiveness: evidence based and best practice• 
Organisation and innovation• 
Justice• 
Population mobility and new challenges in treatment • 
and prevention
The growth and role of spirituality in addiction • 
treatments
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2–5 June 2009
EAHIL Workshop 2009. Working with others: 
Explore, engage, extend! 
Venue: Dublin Castle 
Organised by / Contact: Health Sciences 
Libraries Group, in association with the National 
Documentation Centre on Drug Use, Health 
Research Board. Contact Louise Farragher (Chair, 
Local Organising Committee.) 
Email: lfarragher@hrb.ie 
www.eahil2009.ie 
Information: The European Association for 
Health Information and Libraries (EAHIL) 
Workshop will be the largest health library 
and information event of its kind in Ireland. 
This workshop offers a packed and varied 
programme with parallel interactive workshops, 
paper presentations and plenary sessions that 
aim to explore the nature of collaborative work 
among health librarians and health information 
professionals.  Join over 200 health librarians and 
information professionals from Ireland, Europe 
and beyond and explore issues including:
Teaching and research support ■
Consumer health issues ■
Information literacy  ■
Health technology assessments  ■
Refl ective practice ■
Collaborative work in practice ■
17–19 June 2009
Hepatitis C 3rd International Conference: The 
Third Decade and Beyond
Venue: Dublin Castle, Dublin 
Organised by / Contact: The Consultative 
Council on Hepatitis C, in association with the 
Department of Health and Children and the 
Health Service Executive 
Email: paulenemckeever@conferenceorganisers.ie 
www.hepc2009.com/
Information: This three-day conference offers 
two parallel programmes:
Day 1: a half day dedicated to issues relating to 
primary and community care management of 
Hepatitis C. 
Days 2 and 3: 
Programme 1: Scientifi c/Clinical 
Some of the world’s leading experts will share 
their insights, excitement and commitment 
to understanding the Hepatitis C virus and to 
developing more effective ways of preventing 
and treating the disease. Many of the scientifi c/
clinical speakers will participate in both the 
academic and the patient-focused programmes. 
Programme 2: Living with Hepatitis C
October
29–31 October 2009
2009 International conference and annual 
meeting for the WHO European Network for 
Prison and Health. What works in the prevention 
and control of major communicable diseases 
in prison? 
Venue: Offi ces of the Ministry of Health, Madrid 
Organised by / Contact: WHO European 
Network for Prison and Health 
More information regarding the event, 
registration procedure, accommodation and 
submission of abstracts will follow shortly. 
www.euro.who.int/prisons/
meetings/20090123_1 
Information: This international conference will 
address the health problems related to major 
communicable diseases in prisons and will 
examine best practices in implementing prison 
health services. Prison visits will be organised. 
The Alcohol and Drug Research Unit (ADRU) of the Health Research Board is a multi-
disciplinary team of researchers and information specialists who provide objective, reliable 
and comparable information on the drug and alcohol situation, its consequences and 
responses in Ireland. 
The ADRU maintains two national drug-related surveillance systems and is the national 
focal point for the European Monitoring Centre for Drugs and Drug Addiction. The unit also 
manages the National Documentation Centre on Drug Use. 
The ADRU disseminates research fi ndings, information and news through its quarterly 
newsletter, Drugnet Ireland, and the HRB series publications. Through its activities, the ADRU 
aims to inform policy and practice in relation to drug and alcohol use.
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